<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>7382743</id><passage><infon key="name_3">surname:Lei;given-names:Ping</infon><infon key="name_2">surname:Sun;given-names:Shiran</infon><infon key="name_1">surname:Li;given-names:Qianru</infon><infon key="name_0">surname:Li;given-names:Heli</infon><infon key="article-id_pmid">32724827</infon><infon key="year">2020</infon><infon key="article-id_pmc">7382743</infon><infon key="article-id_doi">10.1155/2020/3067273</infon><infon key="type">front</infon><infon key="elocation-id">3067273</infon><infon key="volume">2020</infon><infon key="license">This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon><infon key="section_type">TITLE</infon><infon key="journal">J Immunol Res; 2020 ; 2020 3067273. doi:10.1155/2020/3067273</infon><infon key="name_5">surname:Shen;given-names:Guanxin</infon><infon key="name_4">surname:Cai;given-names:Xiong</infon><infon key="authors">Li H, Li Q, Sun S, Lei P, Cai X, Shen G, </infon><offset>0</offset><text>Integrated Bioinformatics Analysis Identifies ELAVL1 and APP as Candidate Crucial Genes for Crohn's Disease</text><annotation id="2"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="46" length="6"/><text>ELAVL1</text></annotation><annotation id="3"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="92" length="15"/><text>Crohn's Disease</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>108</offset><text>Immune imbalance and barrier destruction of intestinal mucosa are the central pathogenic factors of Crohn's disease (CD). In this study, three independent microarray studies of CD were integrated and 9912 differentially expressed genes (DEGs) were analysed by NetworkAnalyst to screen candidate crucial genes. NetworkAnalyst identified ELAV-like RNA binding protein 1 (ELAVL1) as the most crucial upregulated gene and amyloid-beta precursor protein (APP) as the most crucial downregulated gene in peripheral blood of CD patients. By computing significance with hypergeometric test based on the KEGG pathway database, upregulated DEGs highlight the pathways of T cell receptor signaling and the differentiation of T helpers. Downregulated DEGs were found enriched in pathways in multiple cancers, MAPK signaling, Rap1 signaling, and PI3K-AKT signaling. Further taking all DEGs together, Gene Set Enrichment Analysis (GSEA) brought out the NOD-like receptor (NLR) signaling pathway which could be regulated by ELAVL1. xCell found decreased naive and differentiated T cell proportions in the peripheral blood of CD patients suggesting T cell migration to the intestinal tissue and/or exhaustion. Further, ELAVL1 expression correlating with multiple T cell proportions suggests that ELAVL1 may regulate T cell activation. These findings illustrated that ELAVL1 and APP were candidate crucial genes in the peripheral blood of CD patients. ELAVL1 possibly acts as a key regulator of T cell activation via the NLR signaling pathway. APP might be a downstream effector of infliximab treatment connecting with MAPK signaling.</text><annotation id="20"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="444" length="31"/><text>ELAV-like RNA binding protein 1</text></annotation><annotation id="21"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="477" length="6"/><text>ELAVL1</text></annotation><annotation id="22"><infon key="identifier">351</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">56379</infon><location offset="526" length="30"/><text>amyloid-beta precursor protein</text></annotation><annotation id="23"><infon key="identifier">5906</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2162</infon><location offset="920" length="4"/><text>Rap1</text></annotation><annotation id="24"><infon key="identifier">207</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3785</infon><location offset="945" length="3"/><text>AKT</text></annotation><annotation id="25"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="1116" length="6"/><text>ELAVL1</text></annotation><annotation id="26"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="1310" length="6"/><text>ELAVL1</text></annotation><annotation id="27"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="1387" length="6"/><text>ELAVL1</text></annotation><annotation id="28"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="1458" length="6"/><text>ELAVL1</text></annotation><annotation id="29"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="1542" length="6"/><text>ELAVL1</text></annotation><annotation id="30"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="628" length="8"/><text>patients</text></annotation><annotation id="31"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="1220" length="8"/><text>patients</text></annotation><annotation id="32"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="1532" length="8"/><text>patients</text></annotation><annotation id="33"><infon key="Identifier">MESH:D000069285</infon><infon key="type">Chemical</infon><location offset="1672" length="10"/><text>infliximab</text></annotation><annotation id="34"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="208" length="15"/><text>Crohn's disease</text></annotation><annotation id="35"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="895" length="7"/><text>cancers</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1725</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1741</offset><text>Crohn's disease (CD), as a systemic inflammatory disease, mainly influences the gastrointestinal tract with a wide range of contributing factors including host genetics, immune system, environmental exposures, and the gut microbiome. Although the pathogenesis is complex, the decades of studies have illustrated that CD is caused by environmental factors that broke the mucosal barrier and increased the luminal antigens into the lamina propria. Different innate immune cells, like dendritic cells, recognize the antigens via pattern recognition receptors, such as Toll-like receptors (TLR) and NLR, and then regulate the activation of T cells.</text><annotation id="40"><infon key="identifier">749906</infon><infon key="type">Species</infon><location offset="1959" length="14"/><text>gut microbiome</text></annotation><annotation id="41"><infon key="Identifier">MESH:D010634</infon><infon key="type">Chemical</infon><location offset="2145" length="7"/><text>luminal</text></annotation><annotation id="42"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="1741" length="15"/><text>Crohn's disease</text></annotation><annotation id="43"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="1777" length="20"/><text>inflammatory disease</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2386</offset><text>Among the factors associated with CD in immune system, T cells were highlighted in CD pathology because about 200 CD risk loci are involved in T cell signaling. Furthermore, the CD4+ T cell, including Th1, Th17, and regulatory T (Treg) cells, were associated with the severity of CD, particularly with active inflammation. In addition, CD8+ T cell transcriptional signatures were identified as reliable prognostic biomarkers in the blood of CD patients. Likewise, numerous studies are devoted to the development of diagnostic methods related to T cells for CD. For example, four CD-related differentially methylated regions were identified in the whole blood. In addition, one T cell subtype from the blood of CD patients is enriched for the CD-risk gene. Nevertheless, the key regulators and mechanisms regulating T cell activation in the blood of CD have not been fully described. Thus, we integrated three independent microarray studies to screen crucial genes in the blood of CD patients.</text><annotation id="50"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="2564" length="3"/><text>CD4</text></annotation><annotation id="51"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="2722" length="3"/><text>CD8</text></annotation><annotation id="52"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="2830" length="8"/><text>patients</text></annotation><annotation id="53"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="3099" length="8"/><text>patients</text></annotation><annotation id="54"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="3369" length="8"/><text>patients</text></annotation><annotation id="55"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="2695" length="12"/><text>inflammation</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3379</offset><text>We performed an integrated bioinformatics analysis to find key regulators by NetworkAnalyst, a web-based visual analytics platform. Indeed, the utility of NetworkAnalyst to identify DEGs and the pathway has been demonstrated recently. For example, network analyses identified HNF4A and PTBP1 as effective biomarkers for Parkinson's disease and 873 DEGs genetically related to insulin resistance.</text><annotation id="59"><infon key="identifier">3172</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">395</infon><location offset="3655" length="5"/><text>HNF4A</text></annotation><annotation id="60"><infon key="identifier">5725</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">49188</infon><location offset="3665" length="5"/><text>PTBP1</text></annotation><annotation id="61"><infon key="Identifier">MESH:D010300</infon><infon key="type">Disease</infon><location offset="3699" length="19"/><text>Parkinson's disease</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3775</offset><text>In this study, we launched a network-based bioinformatics analysis in an attempt to screen DEGs in the blood of CD patients, followed by the KEGG pathway enrichment analysis, GSEA, and interaction network of DEGs. We identified ELAVL1 and APP, previously implicated in regulating the activation of innate immunity and T cells, the most significant up- and downregulated genes. Furthermore, GSEA data show that NOD-like receptor signaling-associated gene signatures are enriched and the xCell analysis indicated that most T cells are significantly decreased in the three microarray studies, which could help in understanding the role of ELAVL1 and APP in the blood of CD patients.</text><annotation id="68"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="4003" length="6"/><text>ELAVL1</text></annotation><annotation id="69"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="4411" length="6"/><text>ELAVL1</text></annotation><annotation id="70"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="3890" length="8"/><text>patients</text></annotation><annotation id="71"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4445" length="8"/><text>patients</text></annotation><annotation id="72"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="3950" length="4"/><text>GSEA</text></annotation><annotation id="73"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="4165" length="4"/><text>GSEA</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>4455</offset><text>2. Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4480</offset><text>2.1. Microarray Source</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4503</offset><text>The microarray studies of CD were downloaded from the Gene Expression Omnibus (GEO) by using the terms "Crohn's disease" and "blood". Three microarray studies were selected for subsequent integrative analysis. GSE86434 included 23 newly diagnosed CD patients and 24 healthy controls (HC). GSE94648 included 22 healthy controls, 9 inactive CD patients and 41 active CD patients. GSE119600 included 47 adult healthy controls, 48 adult CD patients, and 47 child CD patients. PRJEB28822 was chosen to be the verified datasets from the European Nucleotide Archive (ENA), which included 102 pediatric IBD patients and 51 controls, and 95 adult IBD patients and 46 controls, separately.</text><annotation id="85"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4753" length="8"/><text>patients</text></annotation><annotation id="86"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4845" length="8"/><text>patients</text></annotation><annotation id="87"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4871" length="8"/><text>patients</text></annotation><annotation id="88"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4939" length="8"/><text>patients</text></annotation><annotation id="89"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4956" length="5"/><text>child</text></annotation><annotation id="90"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4965" length="8"/><text>patients</text></annotation><annotation id="91"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5102" length="8"/><text>patients</text></annotation><annotation id="92"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5145" length="8"/><text>patients</text></annotation><annotation id="93"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="4607" length="15"/><text>Crohn's disease</text></annotation><annotation id="94"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="5098" length="3"/><text>IBD</text></annotation><annotation id="95"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="5141" length="3"/><text>IBD</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5191</offset><text>2.2. Gene Expression and Connectivity Correlation Assay</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5247</offset><text>To assess the comparability of two datasets, measures of average gene expression and overall connectivity between two datasets were correlated. The higher the correlations, the better the chance of finding similarities between the two datasets at subsequent stages of the analysis. All enrolled datasets with or without batch effect adjustment were examined for average expression correlation (correlation between expression ranks of genes in two studies) and connectivity correlation (correlation between connectivity ranks of genes in two studies) by R package WGCNA. Better comparable datasets were indicated by greater positive correlations and more significant p values.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5923</offset><text>2.3. Integrated Network-Based Bioinformatics Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5977</offset><text>We performed integrated bioinformatics analysis using NetworkAnalyst in accordance with the protocol. After annotating the gene probes to a common Entrez ID, these datasets were normalized per platform requirement and uploaded to the website. DEGs of each dataset were defined by p &lt; 0.05 and log2 fold change &gt; 1. The Venn diagram of DEGs was generated by the FunRich tool (version 3.1).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6370</offset><text>Network-based bioinformatics analysis was performed by NetworkAnalyst according to the pipeline described. The whole blood-specific protein-protein interaction (PPI) of the top 20 DEGs and up- or downregulated genes was constructed per protocol; then, the KEGG pathway enrichment analysis was performed by applying hypergeometric test.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6706</offset><text>2.4. Gene Set Enrichment Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6740</offset><text>Preranked GSEA was analysed using a NetworkAnalyst module powered by R package fgsea. All DEGs ranked by fold changes were put into the analysis, and the results was visualized as interactive heatmaps.</text><annotation id="97"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="6750" length="4"/><text>GSEA</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6942</offset><text>2.5. In Silico Immune Cell Type Enrichment Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6994</offset><text>xCell, a gene signature-based method reliably portraying the cellular heterogeneity landscape of tissue expression profiles, was performed to explore immune cell types, and the proportion of T cells were obtained for each CD and HC sample per instruction.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7250</offset><text>2.6. Statistical Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7276</offset><text>All basic statistical analyses, including the Mann-Whitney test, Pearson correlation, and Spearman correlation were calculated by R software. A p value &lt; 0.05 was considered to be statistically significant. Data were represented by mean and standard deviation (SD) or median and quantile depending on distributions.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>7594</offset><text>3. Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>7605</offset><text>3.1. Screening DEGs by Integrated Bioinformatics Analysis</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7663</offset><text>Three microarray studies (Table 1) were analysed using NetworkAnalyst to screen DEGs in the blood of CD patients. Firstly, these datasets were preprocessed to ensure they are comparable enough. The correlations were positive and the p values were significant in all cases before batch effect adjustments (Figures 1(a)-1(c)). The correlations (cor) for the gene expression and connectivity of GSE86434 and GSE119600 (expression, cor = 0.97, p &lt; 1e - 200; connectivity, cor = 0.74, p &lt; 1e - 200) were better than GSE86434 and GSE94648 (expression, cor = 0.76, p &lt; 1e - 200; connectivity, cor = 0.34, p &lt; 1.6e - 135) or GSE94648 and GSE119600 (expression, cor = 0.75, p &lt; 1e - 200; connectivity, cor = 0.34, p &lt; 1.6e - 135). GSE86434 and GSE119600 were from the same platform (Illumina HumanHT-12 V4.0 expression bead chip). Thus, it is consistent with the notion that datasets from the same platform are more comparable than datasets from different platforms. To remove this batch effect, parametric empirical Bayes frameworks provided by ComBat function were applied by NetworkAnalyst. And the results after batch effect moving were shown in Figures 1(d)-1(f), indicating that the processed data are more comparable. PCA plots with or without batch effect adjustment were visualized in Figure 1(g).</text><annotation id="99"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="7767" length="8"/><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8979</offset><text>Integrated bioinformatics analysis identified 9912 DEGs in the three microarray studies, in which 4705 genes were upregulated and 5207 were downregulated in CD compared with HC. A Venn diagram of integrative analysis DEGs and individual DEGs are shown in Figure 1(h). There were 1361 genes specifically classified by integrated bioinformatics analysis that are weakly but consistently expressed among the three datasets. 2511 genes were identified as lost genes, which are expressed in individual datasets but not in the integrated datasets.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>9521</offset><text>3.2. Top 20 Hub Genes Are Identified by Network-Based Analysis</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9584</offset><text>Firstly, we put all DEGs into network-based analysis per instruction. According to the degree of centrality (DC) and betweenness (BC), the most highly ranked node was APP (DC = 1056; BC = 4730653.29) followed by EGFR (DC = 580; BC = 1711464.65) and ELAVL1 (DC = 574; BC = 1999915.6) and the top 20 hub genes were presented (Table 2). The results of the KEGG pathway enrichment analysis of these 20 genes were shown in Table 3. The whole blood-specific PPI (Figure 2(a)) and enrichment network (Figure 2(b)) were generated by NetworkAnalyst. The zero-order interaction network of these genes contained 20 nodes and 38 edges (Figure 2(a)). The results of pathway enrichment indicated that variables in the blood transcriptome of CD were closely connected to several cancers including colorectal cancer, and also with the PI3K-AKT and MAPK signaling pathways.</text><annotation id="105"><infon key="identifier">1956</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">74545</infon><location offset="9796" length="4"/><text>EGFR</text></annotation><annotation id="106"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="9833" length="6"/><text>ELAVL1</text></annotation><annotation id="107"><infon key="identifier">207</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3785</infon><location offset="10408" length="3"/><text>AKT</text></annotation><annotation id="108"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="10348" length="7"/><text>cancers</text></annotation><annotation id="109"><infon key="Identifier">MESH:D015179</infon><infon key="type">Disease</infon><location offset="10366" length="17"/><text>colorectal cancer</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>10441</offset><text>3.3. ELAVL1 and APP Are Hub Genes Measured by Network Analysis</text><annotation id="111"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="10446" length="6"/><text>ELAVL1</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10504</offset><text>Then, we analysed pathway enriched in up- or downregulated DEGs separately to explore key regulators in the blood of CD patients, by NetworkAnalyst. Upregulated genes in the blood of CD were enriched in the pathways, including T cell receptor signaling pathway, primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, and NF-kappa B signaling pathway (Figure 3(a)). The most crucial gene among upregulated DEGs was ELAVL1 (DC = 357; BC = 709523.17) (Figure 3(b)). Downregulated genes in the blood of CD were enriched in the pathways, including pathways in cancer, MAPK signaling pathway, Rap1 signaling pathway, and PI3K-AKT signaling pathway (Figure 3(c)). The most crucial gene among downregulated DEGs was APP (BC = 1244517.75; DC = 492) (Figure 3(d)).</text><annotation id="119"><infon key="identifier">4790</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2971</infon><location offset="10857" length="10"/><text>NF-kappa B</text></annotation><annotation id="120"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="10950" length="6"/><text>ELAVL1</text></annotation><annotation id="121"><infon key="identifier">5906</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2162</infon><location offset="11123" length="4"/><text>Rap1</text></annotation><annotation id="122"><infon key="identifier">207</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3785</infon><location offset="11156" length="3"/><text>AKT</text></annotation><annotation id="123"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10624" length="8"/><text>patients</text></annotation><annotation id="124"><infon key="Identifier">MESH:D000081207</infon><infon key="type">Disease</infon><location offset="10766" length="24"/><text>primary immunodeficiency</text></annotation><annotation id="125"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="11091" length="6"/><text>cancer</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11291</offset><text>Furthermore, we analysed an AmpliSeq study (PRJEB28822) in the whole peripheral blood of IBD patients. APP expression was significantly reduced in pediatric IBD patients compared with HC (FC = -0.54, p &lt; 0.001), while ELAVL1 was significantly elevated (FC = 0.15, p &lt; 0.05).</text><annotation id="131"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="11509" length="6"/><text>ELAVL1</text></annotation><annotation id="132"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="11384" length="8"/><text>patients</text></annotation><annotation id="133"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="11452" length="8"/><text>patients</text></annotation><annotation id="134"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="11380" length="3"/><text>IBD</text></annotation><annotation id="135"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="11448" length="3"/><text>IBD</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>11568</offset><text>3.4. NOD-like Receptor Signaling Pathway Is Enriched in the Blood of CD by GSEA Analysis</text><annotation id="137"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="11643" length="4"/><text>GSEA</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11657</offset><text>To further clarify the possible mechanism of CD, preranked GSEA was performed to analyse the three microarray datasets separately or integrally selecting fold change as the gene ranking methods (Table 4). As shown in Table 4 and Figures 4(a)-4(d), GSEA analysis suggested that NOD-like receptor signaling pathway is the only enriched gene set we can find in the top 10 enriched gene sets of all three datasets. In addition, the integrated dataset analysed by GSEA also indicated that NOD-like receptor signaling pathway was enriched in CD patients (Figures 4(e) and 4(f)). These results revealed that NOD-like receptor signaling may act as a crucial role in the development of CD.</text><annotation id="142"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12196" length="8"/><text>patients</text></annotation><annotation id="143"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="11716" length="4"/><text>GSEA</text></annotation><annotation id="144"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="11905" length="4"/><text>GSEA</text></annotation><annotation id="145"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="12116" length="4"/><text>GSEA</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>12340</offset><text>3.5. ELAVL1 Expression Correlates with Genes in NLR Signaling Pathway, and APP Expression Is Associated with MAPK Signaling Cross Multiple Datasets</text><annotation id="147"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="12345" length="6"/><text>ELAVL1</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12488</offset><text>To further explore and validate the association between candidate crucial genes and top enriched signaling pathways in CD patients, we analysed the direct correlation between ELAVL1 and major genes in the NLR pathway and correlation between APP and major genes in MAPK signaling by the Pearson correlation. As shown in Figure 5(a), genes in the NLR signaling pathway, including NLRP1, NLRP3, CXCL8, TRAK4, and TNF, were correlated with the expression of ELAVL1 at least in one of the datasets. Additionally, GRB2, FOS, MYD88, MAP3K3, and EGF were found associated with the expression of APP (Figure 5(b)). These results strongly supported the direct correlation between ELAVL1 and NLR signaling, as well as correlations between APP and MAPK signaling in the peripheral blood of CD patients. A slight inconsistency of correlations and significances among three datasets may be due to varied sample sizes and markable heterogeneity of the disease.</text><annotation id="162"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="12663" length="6"/><text>ELAVL1</text></annotation><annotation id="163"><infon key="identifier">22861</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">19080</infon><location offset="12866" length="5"/><text>NLRP1</text></annotation><annotation id="164"><infon key="identifier">114548</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3600</infon><location offset="12873" length="5"/><text>NLRP3</text></annotation><annotation id="165"><infon key="identifier">3576</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">47937</infon><location offset="12880" length="5"/><text>CXCL8</text></annotation><annotation id="166"><infon key="identifier">7124</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">496</infon><location offset="12898" length="3"/><text>TNF</text></annotation><annotation id="167"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="12942" length="6"/><text>ELAVL1</text></annotation><annotation id="168"><infon key="identifier">2885</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1576</infon><location offset="12996" length="4"/><text>GRB2</text></annotation><annotation id="169"><infon key="identifier">2353</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3844</infon><location offset="13002" length="3"/><text>FOS</text></annotation><annotation id="170"><infon key="identifier">4615</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1849</infon><location offset="13007" length="5"/><text>MYD88</text></annotation><annotation id="171"><infon key="identifier">4215</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">69110</infon><location offset="13014" length="6"/><text>MAP3K3</text></annotation><annotation id="172"><infon key="identifier">1950</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1483</infon><location offset="13026" length="3"/><text>EGF</text></annotation><annotation id="173"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="13158" length="6"/><text>ELAVL1</text></annotation><annotation id="174"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12610" length="8"/><text>patients</text></annotation><annotation id="175"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="13269" length="8"/><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>13434</offset><text>3.6. Naive and Differentiated T Cell Proportions in the Peripheral Blood of CD Patients Are Decreased Compared to Health Controls</text><annotation id="177"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="13513" length="8"/><text>Patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13565</offset><text>Previous studies have indicated that distinct T cell subsets, such as Th1/Th17, Tregs, memory, and naive T cells, are activated in the gut of CD patients. Therefore, we performed xCell to explore the signature of T cells in the peripheral blood of CD from the three datasets and found that the altered T cell proportions were one of the hallmarks in the peripheral blood of CD (Figure 6). Specifically, CD4+ T cells were obviously decreased in GSE86434 (Figure 6(a)) and GSE94648 (Figure 6(b); similar trends were also shown in GSE119600 (Figure 6(c)). Because of the essential function of CD4+ T cells in helping the activation of CD8+ T cells, these data also show the decrease of CD8+ T cells in GSE86434 (Figure 6(a)) and GSE94648 (Figure 6(b)), as well as in GSE119600 (Figure 6(b). Similarly, the central memory CD8+ T (Tcm) cells were clearly decreased in all three datasets. Of note, the effector memory CD8+ T (Tem) cells were apparently decreased in the three datasets, which may be a new hallmark in the blood of CD patients. In addition, Th1 cells, the cell type mostly relevant to CD, were disordered in the three datasets. Since T cells are activated and recruited to the intestinal tissue in CD to resist bacterial infections and continuously activated T cells can be exhausted, most T cell subsets decreased in the peripheral blood of CD can be interpreted by T cell migration to the intestinal tissue and/or exhaustion.</text><annotation id="187"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="13968" length="3"/><text>CD4</text></annotation><annotation id="188"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="14155" length="3"/><text>CD4</text></annotation><annotation id="189"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="14383" length="3"/><text>CD8</text></annotation><annotation id="190"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="14477" length="3"/><text>CD8</text></annotation><annotation id="191"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="14248" length="3"/><text>CD8</text></annotation><annotation id="192"><infon key="identifier">100188881</infon><infon key="type">Gene</infon><location offset="14485" length="3"/><text>Tem</text></annotation><annotation id="193"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="14197" length="3"/><text>CD8</text></annotation><annotation id="194"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="13710" length="8"/><text>patients</text></annotation><annotation id="195"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="14592" length="8"/><text>patients</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>15003</offset><text>3.7. ELAVL1 Expression Correlates with Various T Cell Subset Proportions in the Peripheral Blood of CD Patients</text><annotation id="197"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="15008" length="6"/><text>ELAVL1</text></annotation></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15115</offset><text>Since we have found that ELAVL1 is closely associated to NLR signaling, which has an important impact on priming the activation of T cells, we further investigate the association between ELAVL1 expression and the xCell scores of T cells in CD patients by the Spearman correlation. As shown in Figures 7(a)-7(c), different T cell subsets, including CD4+ naive T cells, CD4+ Tcm, CD4+ Tem, CD8+ naive T cells, CD8+ Tcm, and CD8+ Tem, were found positively correlated with ELAVL1 expression in dataset GSE119600 including 95 CD patients (Figure 7(c)). These results suggest that the upregulated expression of ELAVL1 is associated with T cell activation, probably through promoting the NLR signaling pathway. While in GSE86434 and GSE94648, the absence of a significant correlation may due to limited CD sample sizes of the two datasets.</text><annotation id="212"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="15140" length="6"/><text>ELAVL1</text></annotation><annotation id="213"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="15302" length="6"/><text>ELAVL1</text></annotation><annotation id="214"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="15463" length="3"/><text>CD4</text></annotation><annotation id="215"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="15483" length="3"/><text>CD4</text></annotation><annotation id="216"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="15493" length="3"/><text>CD4</text></annotation><annotation id="217"><infon key="identifier">100188881</infon><infon key="type">Gene</infon><location offset="15498" length="3"/><text>Tem</text></annotation><annotation id="218"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="15503" length="3"/><text>CD8</text></annotation><annotation id="219"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="15523" length="3"/><text>CD8</text></annotation><annotation id="220"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="15537" length="3"/><text>CD8</text></annotation><annotation id="221"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="15585" length="6"/><text>ELAVL1</text></annotation><annotation id="222"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="15721" length="6"/><text>ELAVL1</text></annotation><annotation id="223"><infon key="identifier">100188881</infon><infon key="type">Gene</infon><location offset="15542" length="3"/><text>Tem</text></annotation><annotation id="224"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="15358" length="8"/><text>patients</text></annotation><annotation id="225"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="15640" length="8"/><text>patients</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>15951</offset><text>4. Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>15965</offset><text>Up to date, the immunological pathogenesis of CD continues to be complex, and finding the key regulators of the immune response is essential for knowing the disease and improving the clinical management of CD. Specifically, investigations focusing on exploring CD pathogenesis and identifying therapeutic targets are warranted for the discovery of effective drugs. Here, we identified the candidate crucial genes in the peripheral blood of CD by a network-based analysis of NCBI GEO datasets GSE86434, GSE94648, and GSE119600. Integrative analysis identified 9912 DEGs among these datasets. ELAVL1 and APP were confirmed as the most significant up- and downregulated genes by NetworkAnalyst. Furthermore, the differential expression significances of the two hub genes were validated by an AmpliSeq dataset PRJEB28822, indicating that ELAVL1 and APP may be potential biomarkers for CD patients.</text><annotation id="229"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="16556" length="6"/><text>ELAVL1</text></annotation><annotation id="230"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="16799" length="6"/><text>ELAVL1</text></annotation><annotation id="231"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="16849" length="8"/><text>patients</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>16859</offset><text>ELAVL1, also known as Hu antigen R (HuR), is an abundant RNA binding protein that can affect the stability and translation of many RNAs and participate in the regulation of chronic inflammation and cancer progression. It has been identified that ELAVL1 was increased after cellular stress with protective activities, which is positively regulated by NF-kappaB and Smads. Furthermore, the increase of ELAVL1 was confirmed to suppress inflammatory responses in mice, suggesting the important role of ELAVL1 as a posttranscriptional mediator for inflammation. However, it is worth noting that the increased expression of ELAVL1 is identified to promote the overexpression of COX-2, and thus contributing to the growth of colon cancer, whose risk is increased in the setting of CD. Moreover, the influence of ELAVL1 in promoting malignant transformation has been well documented in multiple cancers. That is in consistent with our pathway enrichment of top 20 hub genes indicating that variables in blood transcriptome of CD were closely connected to several cancers including colorectal cancer. The pathway enrichment of top 20 hub genes also shed light on the PI3K-AKT and MAPK signaling pathways, that is in line with investigations that phosphorylation by p38 MAPK results in the accumulation of ELAVL1 in the cytoplasm and the elevation of ELAVL1 is essential for enhancing the proliferation of gastric cancer cells, which depends on the activation of PI3K-AKT and NF-kappaB signaling. Our results highlight the crucial role of ELAVL1 in connecting inflammatory meditation with tumorigenesis, suggesting the potential role of ELAVL1 in carcinogenesis of colorectal cancer in the background of CD.</text><annotation id="259"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="16859" length="6"/><text>ELAVL1</text></annotation><annotation id="260"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="16881" length="12"/><text>Hu antigen R</text></annotation><annotation id="261"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="16895" length="3"/><text>HuR</text></annotation><annotation id="262"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="17105" length="6"/><text>ELAVL1</text></annotation><annotation id="263"><infon key="identifier">4790</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2971</infon><location offset="17209" length="9"/><text>NF-kappaB</text></annotation><annotation id="264"><infon key="identifier">15568</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="17259" length="6"/><text>ELAVL1</text></annotation><annotation id="265"><infon key="identifier">15568</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="17357" length="6"/><text>ELAVL1</text></annotation><annotation id="266"><infon key="identifier">15568</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="17477" length="6"/><text>ELAVL1</text></annotation><annotation id="267"><infon key="identifier">4513</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">5017</infon><location offset="17531" length="5"/><text>COX-2</text></annotation><annotation id="268"><infon key="identifier">15568</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="17664" length="6"/><text>ELAVL1</text></annotation><annotation id="269"><infon key="identifier">207</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3785</infon><location offset="18022" length="3"/><text>AKT</text></annotation><annotation id="270"><infon key="identifier">15568</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="18155" length="6"/><text>ELAVL1</text></annotation><annotation id="271"><infon key="identifier">15568</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="18200" length="6"/><text>ELAVL1</text></annotation><annotation id="272"><infon key="identifier">207</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3785</infon><location offset="18317" length="3"/><text>AKT</text></annotation><annotation id="273"><infon key="identifier">4790</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2971</infon><location offset="18325" length="9"/><text>NF-kappaB</text></annotation><annotation id="274"><infon key="identifier">15568</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="18388" length="6"/><text>ELAVL1</text></annotation><annotation id="275"><infon key="identifier">15568</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="18486" length="6"/><text>ELAVL1</text></annotation><annotation id="276"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="17318" length="4"/><text>mice</text></annotation><annotation id="277"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="17040" length="12"/><text>inflammation</text></annotation><annotation id="278"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="17057" length="6"/><text>cancer</text></annotation><annotation id="279"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="17402" length="12"/><text>inflammation</text></annotation><annotation id="280"><infon key="Identifier">MESH:D015179</infon><infon key="type">Disease</infon><location offset="17577" length="12"/><text>colon cancer</text></annotation><annotation id="281"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="17746" length="7"/><text>cancers</text></annotation><annotation id="282"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="17914" length="7"/><text>cancers</text></annotation><annotation id="283"><infon key="Identifier">MESH:D015179</infon><infon key="type">Disease</infon><location offset="17932" length="17"/><text>colorectal cancer</text></annotation><annotation id="284"><infon key="Identifier">MESH:D013274</infon><infon key="type">Disease</infon><location offset="18255" length="14"/><text>gastric cancer</text></annotation><annotation id="285"><infon key="Identifier">MESH:D015179</infon><infon key="type">Disease</infon><location offset="18496" length="35"/><text>carcinogenesis of colorectal cancer</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18557</offset><text>APP has been known as central to the pathogenesis of Alzheimer's disease (AD) and has been confirmed as the potential biomarker in predicting brain amyloid-beta burden. Although the specific mechanism coexisting in AD and CD is still unclear, it has been demonstrated that there are genetic factors overlapping between AD and CD. Besides, the immune response is considered one of major contributors in both AD and CD. A recent review highlights the influence of the peripheral immune system in AD, such as monocytes and lymphocytes, which have been linked to CD in a number of studies. This overlap in the pathogenesis between the two diseases may suggest the potential central role of APP in CD pathogenesis. Though literature about APP in CD is very limited, we can still note that Apolipoprotein E (APOE), widely found increased in serum of CD patients who were primary nonrespondents or had responded clinically and serologically after infliximab treatment of CD, can increase transcription of APP significantly. Next, APP can active the MAPK signaling pathway, which is one of the top enriched gene sets in our pathway enrichment analysis of top 20 hub genes. Since detailed mechanism about infliximab treatment in CD has not been fully elucidated, APP may be predicted as a downstream effector of the treatment which is worthy of further investigation.</text><annotation id="297"><infon key="identifier">348</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">30951</infon><location offset="19341" length="16"/><text>Apolipoprotein E</text></annotation><annotation id="298"><infon key="identifier">348</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">30951</infon><location offset="19359" length="4"/><text>APOE</text></annotation><annotation id="299"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="19404" length="8"/><text>patients</text></annotation><annotation id="300"><infon key="Identifier">MESH:D000069285</infon><infon key="type">Chemical</infon><location offset="19497" length="10"/><text>infliximab</text></annotation><annotation id="301"><infon key="Identifier">MESH:D000069285</infon><infon key="type">Chemical</infon><location offset="19753" length="10"/><text>infliximab</text></annotation><annotation id="302"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="18610" length="19"/><text>Alzheimer's disease</text></annotation><annotation id="303"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="18631" length="2"/><text>AD</text></annotation><annotation id="304"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="18772" length="2"/><text>AD</text></annotation><annotation id="305"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="18876" length="2"/><text>AD</text></annotation><annotation id="306"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="18964" length="2"/><text>AD</text></annotation><annotation id="307"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="19051" length="2"/><text>AD</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19916</offset><text>The results from GSEA of the individual and overall databases highlight the NOD-like receptor signaling pathway in the blood of CD patients. NOD1 and NOD2, members of the NOD-like receptor family, are two important mediators of inflammation induced by endoplasmic reticulum stress, which is a major contributor to CD. In addition to the roles in regulating innate immune responses, there are plenty of evidences that NOD1 and NOD2 signaling have an impact on adaptive immune responses. In mice, NOD1 and NOD2 signaling are involved in the activation of Th1, Th2, and Th17 cells. NOD2 also can drive CD8+ T cell activation via the cross-presentation pathway. Our integrative analysis also highlights the pathway of the T cell receptor signaling pathway and the differentiation of Th1, Th2, and Th17, which act essential roles in the pathogenesis of CD. It is reasonable for us to assume that the NLR signaling pathway may work as a key regulator of CD pathology by activating T cells. Moreover, the highest ranking of the integrated dataset analysed by GSEA is the MAPK signaling pathway, followed by the Rap1 signaling pathway. As known, Rap1 plays an essential role in regulating the activation of MAPK, which is definitely involved in the development of CD and is an effective target for the treatment of CD. Therefore, it will be interesting to focus linkage between APP and MAPK and investigation of their role in the progression of CD seems to be promising.</text><annotation id="323"><infon key="identifier">10392</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4440</infon><location offset="20057" length="4"/><text>NOD1</text></annotation><annotation id="324"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="20066" length="4"/><text>NOD2</text></annotation><annotation id="325"><infon key="identifier">10392</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4440</infon><location offset="20333" length="4"/><text>NOD1</text></annotation><annotation id="326"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="20342" length="4"/><text>NOD2</text></annotation><annotation id="327"><infon key="identifier">107607</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4440</infon><location offset="20411" length="4"/><text>NOD1</text></annotation><annotation id="328"><infon key="identifier">257632</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="20420" length="4"/><text>NOD2</text></annotation><annotation id="329"><infon key="identifier">257632</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="20495" length="4"/><text>NOD2</text></annotation><annotation id="330"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="20515" length="3"/><text>CD8</text></annotation><annotation id="331"><infon key="identifier">5906</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2162</infon><location offset="21020" length="4"/><text>Rap1</text></annotation><annotation id="332"><infon key="identifier">5906</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2162</infon><location offset="21054" length="4"/><text>Rap1</text></annotation><annotation id="333"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="20047" length="8"/><text>patients</text></annotation><annotation id="334"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="20405" length="4"/><text>mice</text></annotation><annotation id="335"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="19933" length="4"/><text>GSEA</text></annotation><annotation id="336"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="20968" length="4"/><text>GSEA</text></annotation><annotation id="337"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="20144" length="12"/><text>inflammation</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21379</offset><text>The adaptive immune system is considered the key regulator of the pathogenesis of CD. When the intestinal barrier is broken, pattern recognition receptors, such as TLR and NLR, recognize the microbe-associated molecular patterns, thus promoting the activation and differentiation of T cells. Especially, CD4+ T cells are activated and differentiated into Th1/Th17, help the development of memory T cells, and then recruited to the gut to fight against the infection of bacteria, fungi, and viruses. However, continuous T cell activation will aggravate inflammatory damage and will even lead to the exhaustion of T cells. Of note, the exhaustion of T cells regularly impedes the ability to defeat viral infection and promote the occurrence of cancer. Interestingly, the data of xCell indicated that CD4+ and CD8+ T cell proportions are obviously reduced in the blood, which may be caused by the increased migration of T cells into the gut and/or the exhaustion of T cells. Consistent with FACS data from other literatures, our xCell analysis highlight the decrease of CD8+ Tem as a general signature in the blood of CD, which is conventionally considered a cytotoxic cell type to defect the infection of virus. Although little is known about the detail mechanism, these phenomena suggest that the decrease of T cells, especially the CD8+ Tem, in the peripheral blood may be a novel feature for certain CD patients.</text><annotation id="351"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="21683" length="3"/><text>CD4</text></annotation><annotation id="352"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="22177" length="3"/><text>CD4</text></annotation><annotation id="353"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="22186" length="3"/><text>CD8</text></annotation><annotation id="354"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="22446" length="3"/><text>CD8</text></annotation><annotation id="355"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="22711" length="3"/><text>CD8</text></annotation><annotation id="356"><infon key="identifier">100188881</infon><infon key="type">Gene</infon><location offset="22716" length="3"/><text>Tem</text></annotation><annotation id="357"><infon key="identifier">100188881</infon><infon key="type">Gene</infon><location offset="22451" length="3"/><text>Tem</text></annotation><annotation id="358"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="22783" length="8"/><text>patients</text></annotation><annotation id="359"><infon key="Identifier">MESH:D008569</infon><infon key="type">Disease</infon><location offset="21768" length="8"/><text>memory T</text></annotation><annotation id="360"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="21835" length="9"/><text>infection</text></annotation><annotation id="361"><infon key="Identifier">MESH:D001102</infon><infon key="type">Disease</infon><location offset="22075" length="15"/><text>viral infection</text></annotation><annotation id="362"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="22121" length="6"/><text>cancer</text></annotation><annotation id="363"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="22569" length="9"/><text>infection</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22793</offset><text>As known, ELAVL1/HuR acts as a central posttranscriptional regulator of NOD2 expression, and HuR silencing can reduce NOD2 expression and mRNA stability. In addition, HuR stimulated by integrin engagement and the level of HuR nuclear export are definitely involved in the activation of T cells. Interestingly, we found that ELAVL1 expression showed strong positive correlations with multiple T cell subset proportions in GSE119600. The association supports the idea that ELAVL1 can modulate the immune response by activating the T cells. However, we cannot demonstrate the regulatory roles of ELAVL1 on T cell activation in the current transcriptome analysis; further investigation in an animal model will be meaningful and straightforward.</text><annotation id="374"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="22803" length="6"/><text>ELAVL1</text></annotation><annotation id="375"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="22810" length="3"/><text>HuR</text></annotation><annotation id="376"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="22865" length="4"/><text>NOD2</text></annotation><annotation id="377"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="22886" length="3"/><text>HuR</text></annotation><annotation id="378"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="22911" length="4"/><text>NOD2</text></annotation><annotation id="379"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="22960" length="3"/><text>HuR</text></annotation><annotation id="380"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="23015" length="3"/><text>HuR</text></annotation><annotation id="381"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="23117" length="6"/><text>ELAVL1</text></annotation><annotation id="382"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="23264" length="6"/><text>ELAVL1</text></annotation><annotation id="383"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="23386" length="6"/><text>ELAVL1</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23534</offset><text>In conclusion, our study suggests that ELAVL1 and APP are candidate crucial genes in the blood of CD and highlights the function of the NLR signaling pathway in priming the activation of T cells of CD. ELAVL1 may modulate the immune response of CD via the NLR signaling pathway and in turn regulate T cells status. APP could be a downstream effector of infliximab treatment connecting with MAPK signaling (a schematic diagram representing a possible mechanism is shown in Figure 8). Our analysis will be helpful for further investigation and understanding of the mechanism of ELAVL1 and APP in CD pathogenesis.</text><annotation id="388"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="23573" length="6"/><text>ELAVL1</text></annotation><annotation id="389"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="23736" length="6"/><text>ELAVL1</text></annotation><annotation id="390"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="24110" length="6"/><text>ELAVL1</text></annotation><annotation id="391"><infon key="Identifier">MESH:D000069285</infon><infon key="type">Chemical</infon><location offset="23887" length="10"/><text>infliximab</text></annotation></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>24145</offset><text>Data Availability</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>24163</offset><text>The data used to support the findings of this study are available from the corresponding author upon request.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>24273</offset><text>Conflicts of Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>24295</offset><text>The authors declare no conflicts of interest.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title_1</infon><offset>24341</offset><text>Authors' Contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>24364</offset><text>Heli Li and Xiong Cai designed the study, analysed the data, and wrote the manuscript. Qianru Li and Shiran Sun analysed the data. Xiong Cai, Ping Lei, and Guanxin Shen provided funding.</text></passage><passage><infon key="name_3">surname:Verstockt;given-names:B.</infon><infon key="name_2">surname:Sudhakar;given-names:P.</infon><infon key="name_1">surname:Madgwick;given-names:M.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Seyed Tabib;given-names:N. S.</infon><infon key="fpage">p. gutjnl-2019-320065</infon><infon key="pub-id_doi">10.1136/gutjnl-2019-320065</infon><infon key="year">2020</infon><infon key="source">Gut</infon><infon key="type">ref</infon><infon key="name_5">surname:Vermeire;given-names:S.</infon><infon key="name_4">surname:Korcsmaros;given-names:T.</infon><offset>24551</offset><text>Big data in IBD: big progress for clinical practice</text><annotation id="393"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="24563" length="3"/><text>IBD</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84928038337</infon><infon key="volume">7</infon><infon key="name_2">surname:Ho;given-names:G.-T.</infon><infon key="name_1">surname:Satsangi;given-names:J.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Boyapati;given-names:R.</infon><infon key="fpage">p. 44</infon><infon key="pub-id_doi">10.12703/P7-44</infon><infon key="year">2015</infon><infon key="source">F1000prime reports</infon><infon key="type">ref</infon><offset>24603</offset><text>Pathogenesis of Crohn's disease</text><annotation id="395"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="24619" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85064722534</infon><infon key="name_2">surname:Kleist;given-names:A.</infon><infon key="name_1">surname:Krauss;given-names:E.</infon><infon key="name_0">surname:Petruo;given-names:V. A.</infon><infon key="fpage">473</infon><infon key="issue">4</infon><infon key="pub-id_doi">10.1055/a-0838-6371</infon><infon key="pub-id_pmid">30965377</infon><infon key="year">2019</infon><infon key="source">Zeitschrift fur Gastroenterologie</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="section_type">REF</infon><infon key="lpage">483</infon><offset>24635</offset><text>Perceived distress, personality characteristics, coping strategies and psychosocial impairments in a national German multicenter cohort of patients with Crohn's disease and ulcerative colitis</text><annotation id="400"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="24774" length="8"/><text>patients</text></annotation><annotation id="401"><infon key="Identifier">MESH:C535569</infon><infon key="type">Disease</infon><location offset="24706" length="24"/><text>psychosocial impairments</text></annotation><annotation id="402"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="24788" length="15"/><text>Crohn's disease</text></annotation><annotation id="403"><infon key="Identifier">MESH:D003093</infon><infon key="type">Disease</infon><location offset="24808" length="18"/><text>ulcerative colitis</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84940771118</infon><infon key="name_2">surname:van Sommeren;given-names:S.</infon><infon key="name_1">surname:International Multiple Sclerosis Genetics Consortium</infon><infon key="name_0">surname:Liu;given-names:J. Z.</infon><infon key="fpage">979</infon><infon key="issue">9</infon><infon key="pub-id_doi">10.1038/ng.3359</infon><infon key="pub-id_pmid">26192919</infon><infon key="year">2015</infon><infon key="source">Nature Genetics</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="section_type">REF</infon><infon key="lpage">986</infon><offset>24827</offset><text>Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations</text><annotation id="405"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="24884" length="26"/><text>inflammatory bowel disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84923326765</infon><infon key="name_2">surname:Zhu;given-names:J.</infon><infon key="name_1">surname:Marson;given-names:A.</infon><infon key="name_0">surname:Farh;given-names:K. K.-H.</infon><infon key="fpage">337</infon><infon key="issue">7539</infon><infon key="pub-id_doi">10.1038/nature13835</infon><infon key="pub-id_pmid">25363779</infon><infon key="year">2015</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">518</infon><infon key="section_type">REF</infon><infon key="lpage">343</infon><offset>24964</offset><text>Genetic and epigenetic fine mapping of causal autoimmune disease variants</text><annotation id="407"><infon key="Identifier">MESH:D001327</infon><infon key="type">Disease</infon><location offset="25010" length="18"/><text>autoimmune disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-80053414769</infon><infon key="name_2">surname:McKinney;given-names:E. F.</infon><infon key="name_1">surname:Lyons;given-names:P. A.</infon><infon key="name_0">surname:Lee;given-names:J. C.</infon><infon key="fpage">4170</infon><infon key="issue">10</infon><infon key="pub-id_doi">10.1172/JCI59255</infon><infon key="pub-id_pmid">21946256</infon><infon key="year">2011</infon><infon key="source">The Journal of Clinical Investigation</infon><infon key="type">ref</infon><infon key="volume">121</infon><infon key="section_type">REF</infon><infon key="lpage">4179</infon><offset>25038</offset><text>Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis</text><annotation id="412"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="25067" length="3"/><text>CD8</text></annotation><annotation id="413"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="25102" length="8"/><text>patients</text></annotation><annotation id="414"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="25116" length="13"/><text>Crohn disease</text></annotation><annotation id="415"><infon key="Identifier">MESH:D003093</infon><infon key="type">Disease</infon><location offset="25134" length="18"/><text>ulcerative colitis</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85065295666</infon><infon key="name_2">surname:Noor;given-names:N. M.</infon><infon key="name_1">surname:Lee;given-names:J. C.</infon><infon key="name_0">surname:Biasci;given-names:D.</infon><infon key="fpage">1386</infon><infon key="issue">8</infon><infon key="pub-id_doi">10.1136/gutjnl-2019-318343</infon><infon key="pub-id_pmid">31030191</infon><infon key="year">2019</infon><infon key="source">Gut</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="section_type">REF</infon><infon key="lpage">1395</infon><offset>25153</offset><text>A blood-based prognostic biomarker in IBD</text><annotation id="417"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="25191" length="3"/><text>IBD</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84998610927</infon><infon key="volume">7</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Ventham;given-names:N. T.</infon><infon key="fpage">p. 13507</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1038/ncomms13507</infon><infon key="year">2016</infon><infon key="source">Nature Communications</infon><infon key="type">ref</infon><offset>25195</offset><text>Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease</text><annotation id="419"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="25293" length="26"/><text>inflammatory bowel disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85061005653</infon><infon key="name_2">surname:Vila;given-names:A. V.</infon><infon key="name_1">surname:Voskuil;given-names:M. D.</infon><infon key="name_0">surname:Uniken Venema;given-names:W. T.</infon><infon key="fpage">812</infon><infon key="issue">3</infon><infon key="pub-id_doi">10.1053/j.gastro.2018.10.046</infon><infon key="pub-id_pmid">30391472</infon><infon key="year">2019</infon><infon key="source">Gastroenterology</infon><infon key="type">ref</infon><infon key="volume">156</infon><infon key="section_type">REF</infon><infon key="lpage">815.e22</infon><offset>25320</offset><text>Single-cell RNA sequencing of blood and ileal T cells from patients with Crohn's disease reveals tissue-specific characteristics and drug targets</text><annotation id="422"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="25379" length="8"/><text>patients</text></annotation><annotation id="423"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="25393" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="name_3">surname:Hancock;given-names:R. E. W.</infon><infon key="pub-id_other">2-s2.0-85068482670</infon><infon key="name_2">surname:Ewald;given-names:J.</infon><infon key="name_1">surname:Soufan;given-names:O.</infon><infon key="name_0">surname:Zhou;given-names:G.</infon><infon key="fpage">W234</infon><infon key="issue">W1</infon><infon key="pub-id_doi">10.1093/nar/gkz240</infon><infon key="pub-id_pmid">30931480</infon><infon key="year">2019</infon><infon key="source">Nucleic acids research</infon><infon key="type">ref</infon><infon key="volume">47</infon><infon key="section_type">REF</infon><infon key="lpage">W241</infon><infon key="name_5">surname:Xia;given-names:J.</infon><infon key="name_4">surname:Basu;given-names:N.</infon><offset>25466</offset><text>NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis</text></passage><passage><infon key="pub-id_other">2-s2.0-84923164524</infon><infon key="name_1">surname:Potashkin;given-names:J. A.</infon><infon key="name_0">surname:Santiago;given-names:J. A.</infon><infon key="fpage">2257</infon><infon key="issue">7</infon><infon key="pub-id_doi">10.1073/pnas.1423573112</infon><infon key="pub-id_pmid">25646437</infon><infon key="year">2015</infon><infon key="source">Proceedings of the National Academy of Sciences of the United States of America</infon><infon key="type">ref</infon><infon key="volume">112</infon><infon key="section_type">REF</infon><infon key="lpage">2262</infon><offset>25576</offset><text>Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease</text><annotation id="427"><infon key="identifier">3172</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">395</infon><location offset="25614" length="5"/><text>HNF4A</text></annotation><annotation id="428"><infon key="identifier">5725</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">49188</infon><location offset="25624" length="5"/><text>PTBP1</text></annotation><annotation id="429"><infon key="Identifier">MESH:D010300</infon><infon key="type">Disease</infon><location offset="25671" length="19"/><text>Parkinson's disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85060541567</infon><infon key="name_2">surname:Vastrad;given-names:C.</infon><infon key="name_1">surname:Vastrad;given-names:B.</infon><infon key="name_0">surname:Pujar;given-names:M. K.</infon><infon key="fpage">p. 37</infon><infon key="issue">2</infon><infon key="pub-id_doi">10.3390/biom9020037</infon><infon key="pub-id_pmid">30678306</infon><infon key="year">2019</infon><infon key="source">Biomolecules</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="section_type">REF</infon><offset>25691</offset><text>Integrative analyses of genes associated with subcutaneous insulin resistance</text></passage><passage><infon key="pub-id_other">2-s2.0-77954495173</infon><infon key="name_2">surname:Beccard;given-names:A.</infon><infon key="name_1">surname:Ceballos-Diaz;given-names:C.</infon><infon key="name_0">surname:Chakrabarty;given-names:P.</infon><infon key="fpage">5333</infon><infon key="issue">9</infon><infon key="pub-id_doi">10.4049/jimmunol.0903382</infon><infon key="pub-id_pmid">20368278</infon><infon key="year">2010</infon><infon key="source">The Journal of Immunology</infon><infon key="type">ref</infon><infon key="volume">184</infon><infon key="section_type">REF</infon><infon key="lpage">5343</infon><offset>25769</offset><text>IFN-gamma promotes complement expression and attenuates amyloid plaque deposition in amyloid beta precursor protein transgenic mice</text><annotation id="432"><infon key="identifier">15978</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">55526</infon><location offset="25769" length="9"/><text>IFN-gamma</text></annotation><annotation id="433"><infon key="identifier">351</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">56379</infon><location offset="25854" length="30"/><text>amyloid beta precursor protein</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85057393004</infon><infon key="volume">9</infon><infon key="name_2">surname:Andreadou;given-names:M.</infon><infon key="name_1">surname:Ioakeimidis;given-names:F.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Christodoulou-Vafeiadou;given-names:E.</infon><infon key="fpage">p. 2732</infon><infon key="pub-id_doi">10.3389/fimmu.2018.02732</infon><infon key="year">2018</infon><infon key="source">Frontiers in Immunology</infon><infon key="type">ref</infon><offset>25901</offset><text>Divergent innate and epithelial functions of the RNA-binding protein HuR in intestinal inflammation</text><annotation id="436"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="25970" length="3"/><text>HuR</text></annotation><annotation id="437"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="25988" length="12"/><text>inflammation</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-79960424324</infon><infon key="name_2">surname:Magee;given-names:J. D.</infon><infon key="name_1">surname:Gubin;given-names:M. M.</infon><infon key="name_0">surname:Stellato;given-names:C.</infon><infon key="fpage">441</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.4049/jimmunol.1001881</infon><infon key="pub-id_pmid">21613615</infon><infon key="year">2011</infon><infon key="source">The Journal of Immunology</infon><infon key="type">ref</infon><infon key="volume">187</infon><infon key="section_type">REF</infon><infon key="lpage">449</infon><offset>26001</offset><text>Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR</text><annotation id="439"><infon key="identifier">2625</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1550</infon><location offset="26026" length="6"/><text>GATA-3</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-77955454185</infon><infon key="name_2">surname:Geschwind;given-names:D. H.</infon><infon key="name_1">surname:Horvath;given-names:S.</infon><infon key="name_0">surname:Miller;given-names:J. A.</infon><infon key="fpage">12698</infon><infon key="issue">28</infon><infon key="pub-id_doi">10.1073/pnas.0914257107</infon><infon key="pub-id_pmid">20616000</infon><infon key="year">2010</infon><infon key="source">Proceedings of the National Academy of Sciences of the United States of America</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="section_type">REF</infon><infon key="lpage">12703</infon><offset>26097</offset><text>Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways</text><annotation id="443"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26111" length="5"/><text>human</text></annotation><annotation id="444"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="26121" length="5"/><text>mouse</text></annotation><annotation id="445"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="26158" length="17"/><text>Alzheimer disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84930062965</infon><infon key="name_2">surname:Hancock;given-names:R. E. W.</infon><infon key="name_1">surname:Gill;given-names:E. E.</infon><infon key="name_0">surname:Xia;given-names:J.</infon><infon key="fpage">823</infon><infon key="issue">6</infon><infon key="pub-id_doi">10.1038/nprot.2015.052</infon><infon key="pub-id_pmid">25950236</infon><infon key="year">2015</infon><infon key="source">Nature Protocols</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="section_type">REF</infon><infon key="lpage">844</infon><offset>26185</offset><text>NetworkAnalyst for statistical, visual and network-based meta-analysis of gene expression data</text></passage><passage><infon key="pub-id_other">2-s2.0-85034614124</infon><infon key="name_2">surname:Butte;given-names:A. J.</infon><infon key="name_1">surname:Hu;given-names:Z.</infon><infon key="name_0">surname:Aran;given-names:D.</infon><infon key="fpage">p. 220</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1186/s13059-017-1349-1</infon><infon key="pub-id_pmid">29141660</infon><infon key="year">2017</infon><infon key="source">Genome biology</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="section_type">REF</infon><offset>26280</offset><text>xCell: digitally portraying the tissue cellular heterogeneity landscape</text></passage><passage><infon key="pub-id_other">2-s2.0-85042172801</infon><infon key="name_2">surname:Leal;given-names:R. F.</infon><infon key="name_1">surname:Masamunt;given-names:M. C.</infon><infon key="name_0">surname:Planell;given-names:N.</infon><infon key="fpage">1335</infon><infon key="issue">11</infon><infon key="pub-id_doi">10.1093/ecco-jcc/jjx091</infon><infon key="pub-id_pmid">28981629</infon><infon key="year">2017</infon><infon key="source">Journal of Crohn's &amp; Colitis</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="lpage">1346</infon><offset>26352</offset><text>Usefulness of transcriptional blood biomarkers as a non-invasive surrogate marker of mucosal healing and endoscopic response in ulcerative colitis</text><annotation id="447"><infon key="Identifier">MESH:D003093</infon><infon key="type">Disease</infon><location offset="26480" length="18"/><text>ulcerative colitis</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85065661460</infon><infon key="name_2">surname:Goryca;given-names:K.</infon><infon key="name_1">surname:The Polish PBC study Group</infon><infon key="name_0">surname:Ostrowski;given-names:J.</infon><infon key="fpage">p. 7190</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1038/s41598-019-43699-1</infon><infon key="pub-id_pmid">31076612</infon><infon key="year">2019</infon><infon key="source">Scientific reports</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="section_type">REF</infon><offset>26499</offset><text>Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases</text><annotation id="450"><infon key="Identifier">MESH:D017093</infon><infon key="type">Disease</infon><location offset="26566" length="28"/><text>autoimmune cholestatic liver</text></annotation><annotation id="451"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="26612" length="14"/><text>bowel diseases</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85068538010</infon><infon key="name_2">surname:Lazowska;given-names:I.</infon><infon key="name_1">surname:Dabrowska;given-names:M.</infon><infon key="name_0">surname:Ostrowski;given-names:J.</infon><infon key="fpage">626</infon><infon key="issue">5</infon><infon key="pub-id_doi">10.1093/ecco-jcc/jjy205</infon><infon key="year">2019</infon><infon key="source">Journal of Crohn's &amp; Colitis</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="section_type">REF</infon><infon key="lpage">633</infon><offset>26627</offset><text>Redefining the practical utility of blood transcriptome biomarkers in inflammatory bowel diseases</text><annotation id="453"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="26697" length="27"/><text>inflammatory bowel diseases</text></annotation></passage><passage><infon key="name_3">surname:Sun;given-names:R.</infon><infon key="volume">155</infon><infon key="name_2">surname:Li;given-names:Y.</infon><infon key="name_1">surname:Wu;given-names:K.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Liu;given-names:R.</infon><infon key="fpage">p. 104684</infon><infon key="pub-id_doi">10.1016/j.phrs.2020.104684</infon><infon key="year">2020</infon><infon key="source">Pharmacological Research</infon><infon key="type">ref</infon><infon key="name_4">surname:Li;given-names:X.</infon><offset>26725</offset><text>Human antigen R: a potential therapeutic target for liver diseases</text><annotation id="456"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26725" length="5"/><text>Human</text></annotation><annotation id="457"><infon key="Identifier">MESH:D008107</infon><infon key="type">Disease</infon><location offset="26777" length="14"/><text>liver diseases</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-24944468765</infon><infon key="name_2">surname:Milatos;given-names:S.</infon><infon key="name_1">surname:Papadaki;given-names:O.</infon><infon key="name_0">surname:Katsanou;given-names:V.</infon><infon key="fpage">777</infon><infon key="issue">6</infon><infon key="pub-id_doi">10.1016/j.molcel.2005.08.007</infon><infon key="pub-id_pmid">16168373</infon><infon key="year">2005</infon><infon key="source">Molecular Cell</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="section_type">REF</infon><infon key="lpage">789</infon><offset>26792</offset><text>HuR as a negative posttranscriptional modulator in inflammation</text><annotation id="460"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="26792" length="3"/><text>HuR</text></annotation><annotation id="461"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="26843" length="12"/><text>inflammation</text></annotation></passage><passage><infon key="name_3">surname:Govindaraju;given-names:S.</infon><infon key="pub-id_other">2-s2.0-77951193361</infon><infon key="name_2">surname:Ayupova;given-names:D. A.</infon><infon key="name_1">surname:Singh;given-names:M.</infon><infon key="name_0">surname:Jeyaraj;given-names:S. C.</infon><infon key="fpage">4432</infon><infon key="issue">7</infon><infon key="pub-id_doi">10.1074/jbc.M109.062216</infon><infon key="pub-id_pmid">20018854</infon><infon key="year">2010</infon><infon key="source">The Journal of Biological Chemistry</infon><infon key="type">ref</infon><infon key="volume">285</infon><infon key="section_type">REF</infon><infon key="lpage">4440</infon><infon key="name_4">surname:Lee;given-names:B. S.</infon><offset>26856</offset><text>Transcriptional control of human antigen R by bone morphogenetic protein</text><annotation id="463"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="26883" length="5"/><text>human</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84860332384</infon><infon key="volume">17</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Srikantan;given-names:S.</infon><infon key="fpage">p. 189</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.2741/3921</infon><infon key="year">2012</infon><infon key="source">Frontiers in bioscience</infon><infon key="type">ref</infon><offset>26929</offset><text>HuR function in disease</text><annotation id="465"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="26929" length="3"/><text>HuR</text></annotation></passage><passage><infon key="name_3">surname:Huizenga;given-names:K. A.</infon><infon key="pub-id_other">2-s2.0-0015933126</infon><infon key="name_2">surname:Ilstrup;given-names:D. M.</infon><infon key="name_1">surname:Shorter;given-names:R. G.</infon><infon key="name_0">surname:Weedon;given-names:D. D.</infon><infon key="fpage">1099</infon><infon key="issue">21</infon><infon key="pub-id_doi">10.1056/NEJM197311222892101</infon><infon key="pub-id_pmid">4754948</infon><infon key="year">1973</infon><infon key="source">The New England Journal of Medicine</infon><infon key="type">ref</infon><infon key="volume">289</infon><infon key="section_type">REF</infon><infon key="lpage">1103</infon><infon key="name_4">surname:Taylor;given-names:W. F.</infon><offset>26953</offset><text>Crohn's disease and cancer</text><annotation id="468"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="26953" length="15"/><text>Crohn's disease</text></annotation><annotation id="469"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="26973" length="6"/><text>cancer</text></annotation></passage><passage><infon key="name_3">surname:Thompson;given-names:H.</infon><infon key="pub-id_other">2-s2.0-0019129255</infon><infon key="name_2">surname:Macartney;given-names:J. C.</infon><infon key="name_1">surname:Prior;given-names:P.</infon><infon key="name_0">surname:Gyde;given-names:S. N.</infon><infon key="fpage">1024</infon><infon key="issue">12</infon><infon key="pub-id_doi">10.1136/gut.21.12.1024</infon><infon key="pub-id_pmid">7461462</infon><infon key="year">1980</infon><infon key="source">Gut</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="section_type">REF</infon><infon key="lpage">1029</infon><infon key="name_5">surname:Allan;given-names:R. N.</infon><infon key="name_4">surname:Waterhouse;given-names:J. A.</infon><offset>26980</offset><text>Malignancy in Crohn's disease</text><annotation id="471"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="26994" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="volume">2</infon><infon key="name_2">surname:Gorospe;given-names:M.</infon><infon key="name_1">surname:Lal;given-names:A.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:de Silanes;given-names:I. L.</infon><infon key="fpage">11</infon><infon key="issue">1</infon><infon key="year">2014</infon><infon key="source">RNA Biology</infon><infon key="type">ref</infon><infon key="lpage">13</infon><offset>27010</offset><text>HuR: post-transcriptional paths to malignancy</text><annotation id="474"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="27010" length="3"/><text>HuR</text></annotation><annotation id="475"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="27045" length="10"/><text>malignancy</text></annotation></passage><passage><infon key="volume">38</infon><infon key="name_2">surname:Aslanukova;given-names:L.</infon><infon key="name_1">surname:Furuuchi;given-names:N.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Peng;given-names:W.</infon><infon key="issue">3</infon><infon key="year">2018</infon><infon key="source">Molecular and cellular biology</infon><infon key="type">ref</infon><offset>27056</offset><text>Elevated HuR in pancreas promotes a pancreatitis-like inflammatory microenvironment that facilitates tumor development</text><annotation id="479"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="27065" length="3"/><text>HuR</text></annotation><annotation id="480"><infon key="Identifier">MESH:D010195</infon><infon key="type">Disease</infon><location offset="27092" length="12"/><text>pancreatitis</text></annotation><annotation id="481"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="27157" length="5"/><text>tumor</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85072731946</infon><infon key="volume">6</infon><infon key="name_2">surname:Lopez-Cortes;given-names:A.</infon><infon key="name_1">surname:Guerrero;given-names:S.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Garcia-Cardenas;given-names:J. M.</infon><infon key="fpage">p. 65</infon><infon key="pub-id_doi">10.3389/fmolb.2019.00065</infon><infon key="year">2019</infon><infon key="source">Frontiers in Molecular Biosciences</infon><infon key="type">ref</infon><offset>27175</offset><text>Post-transcriptional regulation of colorectal cancer: a focus on RNA-binding proteins</text><annotation id="483"><infon key="Identifier">MESH:D015179</infon><infon key="type">Disease</infon><location offset="27210" length="17"/><text>colorectal cancer</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85056700742</infon><infon key="name_2">surname:Kitamura;given-names:T.</infon><infon key="name_1">surname:Nomura;given-names:T.</infon><infon key="name_0">surname:Kakuguchi;given-names:W.</infon><infon key="fpage">6269</infon><infon key="issue">12</infon><infon key="pub-id_doi">10.1002/cam4.1877</infon><infon key="pub-id_pmid">30449075</infon><infon key="year">2018</infon><infon key="source">Cancer Medicine</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="section_type">REF</infon><infon key="lpage">6280</infon><offset>27261</offset><text>Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells</text><annotation id="487"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="27319" length="3"/><text>HuR</text></annotation><annotation id="488"><infon key="Identifier">MESH:D013498</infon><infon key="type">Chemical</infon><location offset="27261" length="7"/><text>Suramin</text></annotation><annotation id="489"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="27371" length="11"/><text>oral cancer</text></annotation></passage><passage><infon key="volume">7</infon><infon key="name_2">surname:Kim;given-names:H.-J.</infon><infon key="name_1">surname:Park;given-names:K.-K.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Lee;given-names:S. K.</infon><infon key="issue">1</infon><infon key="year">2017</infon><infon key="source">Scientific reports</infon><infon key="type">ref</infon><offset>27389</offset><text>Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis</text><annotation id="493"><infon key="identifier">6364</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3375</infon><location offset="27415" length="5"/><text>CCL20</text></annotation><annotation id="494"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27389" length="5"/><text>Human</text></annotation><annotation id="495"><infon key="Identifier">MESH:D001943</infon><infon key="type">Disease</infon><location offset="27436" length="40"/><text>osteolytic breast cancer bone metastasis</text></annotation></passage><passage><infon key="name_3">surname:Bengoechea;given-names:R.</infon><infon key="pub-id_other">2-s2.0-68949161769</infon><infon key="name_2">surname:Lopez de Silanes;given-names:I.</infon><infon key="name_1">surname:Cuadrado;given-names:A.</infon><infon key="name_0">surname:Lafarga;given-names:V.</infon><infon key="fpage">4341</infon><infon key="issue">16</infon><infon key="pub-id_doi">10.1128/MCB.00210-09</infon><infon key="pub-id_pmid">19528229</infon><infon key="year">2009</infon><infon key="source">Molecular and Cellular Biology</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="section_type">REF</infon><infon key="lpage">4351</infon><infon key="name_5">surname:Nebreda;given-names:A. R.</infon><infon key="name_4">surname:Fernandez-Capetillo;given-names:O.</infon><offset>27477</offset><text>p38 mitogen-activated protein kinase- and HuR-dependent stabilization of p21Cip1 mRNA mediates the G1/S checkpoint</text><annotation id="499"><infon key="identifier">1432</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">31777</infon><location offset="27477" length="3"/><text>p38</text></annotation><annotation id="500"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="27519" length="3"/><text>HuR</text></annotation><annotation id="501"><infon key="identifier">1026</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">333</infon><location offset="27550" length="7"/><text>p21Cip1</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-57249104900</infon><infon key="name_2">surname:Lee;given-names:M.-G.</infon><infon key="name_1">surname:Ryu;given-names:B.-K.</infon><infon key="name_0">surname:Kang;given-names:M.-J.</infon><infon key="fpage">2030</infon><infon key="issue">6</infon><infon key="pub-id_doi">10.1053/j.gastro.2008.08.009</infon><infon key="pub-id_pmid">18824170</infon><infon key="year">2008</infon><infon key="source">Gastroenterology</infon><infon key="type">ref</infon><infon key="volume">135</infon><infon key="section_type">REF</infon><infon key="lpage">2042.e3</infon><offset>27592</offset><text>NF-kappaB Activates Transcription of the RNA-Binding Factor HuR, via PI3K-AKT Signaling, to Promote Gastric Tumorigenesis</text><annotation id="505"><infon key="identifier">4790</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2971</infon><location offset="27592" length="9"/><text>NF-kappaB</text></annotation><annotation id="506"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="27652" length="3"/><text>HuR</text></annotation><annotation id="507"><infon key="identifier">207</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3785</infon><location offset="27666" length="3"/><text>AKT</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85041744993</infon><infon key="name_2">surname:Villemagne;given-names:V. L.</infon><infon key="name_1">surname:Kaneko;given-names:N.</infon><infon key="name_0">surname:Nakamura;given-names:A.</infon><infon key="fpage">249</infon><infon key="issue">7691</infon><infon key="pub-id_doi">10.1038/nature25456</infon><infon key="pub-id_pmid">29420472</infon><infon key="year">2018</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">554</infon><infon key="section_type">REF</infon><infon key="lpage">254</infon><offset>27714</offset><text>High performance plasma amyloid-beta biomarkers for Alzheimer's disease</text><annotation id="509"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="27766" length="19"/><text>Alzheimer's disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84974528083</infon><infon key="name_2">surname:Schork;given-names:A. J.</infon><infon key="name_1">surname:Wang;given-names:Y.</infon><infon key="name_0">surname:Yokoyama;given-names:J. S.</infon><infon key="fpage">691</infon><infon key="issue">6</infon><infon key="pub-id_doi">10.1001/jamaneurol.2016.0150</infon><infon key="pub-id_pmid">27088644</infon><infon key="year">2016</infon><infon key="source">JAMA Neurology</infon><infon key="type">ref</infon><infon key="volume">73</infon><infon key="section_type">REF</infon><infon key="lpage">697</infon><offset>27786</offset><text>Association between genetic traits for immune-mediated diseases and Alzheimer disease</text><annotation id="511"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="27854" length="17"/><text>Alzheimer disease</text></annotation></passage><passage><infon key="name_3">surname:McLaurin;given-names:J.</infon><infon key="pub-id_other">2-s2.0-85029782085</infon><infon key="name_2">surname:Salter;given-names:M. W.</infon><infon key="name_1">surname:Sengar;given-names:A. S.</infon><infon key="name_0">surname:Jevtic;given-names:S.</infon><infon key="fpage">84</infon><infon key="pub-id_doi">10.1016/j.arr.2017.08.005</infon><infon key="pub-id_pmid">28941639</infon><infon key="year">2017</infon><infon key="source">Ageing Research Reviews</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="section_type">REF</infon><infon key="lpage">94</infon><offset>27872</offset><text>The role of the immune system in Alzheimer disease: etiology and treatment</text><annotation id="513"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="27905" length="17"/><text>Alzheimer disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85068239067</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Neurath;given-names:M. F.</infon><infon key="fpage">970</infon><infon key="issue">8</infon><infon key="pub-id_doi">10.1038/s41590-019-0415-0</infon><infon key="pub-id_pmid">31235952</infon><infon key="year">2019</infon><infon key="source">Nature Immunology</infon><infon key="type">ref</infon><infon key="lpage">979</infon><offset>27947</offset><text>Targeting immune cell circuits and trafficking in inflammatory bowel disease</text><annotation id="515"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="27997" length="26"/><text>inflammatory bowel disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84884166743</infon><infon key="name_2">surname:Papadopoulou;given-names:A.</infon><infon key="name_1">surname:Anagnostopoulos;given-names:A. K.</infon><infon key="name_0">surname:Gazouli;given-names:M.</infon><infon key="fpage">e461</infon><infon key="issue">10</infon><infon key="pub-id_doi">10.1016/j.crohns.2013.02.021</infon><infon key="pub-id_pmid">23562004</infon><infon key="year">2013</infon><infon key="source">Journal of Crohn's &amp; Colitis</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="section_type">REF</infon><infon key="lpage">e470</infon><offset>28024</offset><text>Serum protein profile of Crohn's disease treated with infliximab</text><annotation id="518"><infon key="Identifier">MESH:D000069285</infon><infon key="type">Chemical</infon><location offset="28078" length="10"/><text>infliximab</text></annotation><annotation id="519"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="28049" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="name_3">surname:Sudhof;given-names:T. C.</infon><infon key="pub-id_other">2-s2.0-85009815098</infon><infon key="name_2">surname:Wernig;given-names:M.</infon><infon key="name_1">surname:Zhou;given-names:B.</infon><infon key="name_0">surname:Huang;given-names:Y.-W. A.</infon><infon key="fpage">427</infon><infon key="issue">3</infon><infon key="pub-id_doi">10.1016/j.cell.2016.12.044</infon><infon key="pub-id_pmid">28111074</infon><infon key="year">2017</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">168</infon><infon key="section_type">REF</infon><infon key="lpage">441.e21</infon><offset>28089</offset><text>ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and Abeta secretion</text><annotation id="524"><infon key="identifier">348</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">30951</infon><location offset="28089" length="5"/><text>ApoE2</text></annotation><annotation id="525"><infon key="identifier">348</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">30951</infon><location offset="28096" length="5"/><text>ApoE3</text></annotation><annotation id="526"><infon key="identifier">348</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">30951</infon><location offset="28107" length="5"/><text>ApoE4</text></annotation><annotation id="527"><infon key="identifier">351</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">56379</infon><location offset="28160" length="5"/><text>Abeta</text></annotation></passage><passage><infon key="name_3">surname:Lai;given-names:L.</infon><infon key="pub-id_other">2-s2.0-85068391710</infon><infon key="name_2">surname:Xiong;given-names:G.</infon><infon key="name_1">surname:Ying;given-names:Y.</infon><infon key="name_0">surname:Xu;given-names:J.</infon><infon key="fpage">409</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.3892/mmr.2019.10293</infon><infon key="pub-id_pmid">31180550</infon><infon key="year">2019</infon><infon key="source">Molecular Medicine Reports</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="lpage">416</infon><infon key="name_5">surname:Yang;given-names:Y.</infon><infon key="name_4">surname:Wang;given-names:Q.</infon><offset>28176</offset><text>Amyloid beta precursor protein silencing attenuates epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway</text><annotation id="530"><infon key="identifier">351</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">56379</infon><location offset="28176" length="30"/><text>Amyloid beta precursor protein</text></annotation><annotation id="531"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="28280" length="9"/><text>carcinoma</text></annotation></passage><passage><infon key="name_2">surname:Lu;given-names:C.</infon><infon key="name_1">surname:Chen;given-names:S.</infon><infon key="name_0">surname:Wu;given-names:X.</infon><infon key="fpage">162</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.3892/ijmm.2019.4404</infon><infon key="pub-id_pmid">31746365</infon><infon key="year">2020</infon><infon key="source">International Journal of Molecular Medicine</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="section_type">REF</infon><infon key="lpage">174</infon><offset>28331</offset><text>Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway</text><annotation id="534"><infon key="identifier">351</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">56379</infon><location offset="28331" length="25"/><text>Amyloid precursor protein</text></annotation><annotation id="535"><infon key="Identifier">MESH:D001943</infon><infon key="type">Disease</infon><location offset="28396" length="13"/><text>breast cancer</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84964425113</infon><infon key="name_2">surname:Seyffert;given-names:N.</infon><infon key="name_1">surname:Byndloss;given-names:M. X.</infon><infon key="name_0">surname:Keestra-Gounder;given-names:A. M.</infon><infon key="fpage">394</infon><infon key="issue">7599</infon><infon key="pub-id_doi">10.1038/nature17631</infon><infon key="pub-id_pmid">27007849</infon><infon key="year">2016</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">532</infon><infon key="section_type">REF</infon><infon key="lpage">397</infon><offset>28457</offset><text>NOD1 and NOD2 signalling links ER stress with inflammation</text><annotation id="539"><infon key="identifier">10392</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4440</infon><location offset="28457" length="4"/><text>NOD1</text></annotation><annotation id="540"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="28466" length="4"/><text>NOD2</text></annotation><annotation id="541"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="28503" length="12"/><text>inflammation</text></annotation></passage><passage><infon key="name_3">surname:Nunez;given-names:G.</infon><infon key="pub-id_other">2-s2.0-84918535219</infon><infon key="name_2">surname:Inohara;given-names:N.</infon><infon key="name_1">surname:Warner;given-names:N.</infon><infon key="name_0">surname:Caruso;given-names:R.</infon><infon key="fpage">898</infon><infon key="issue">6</infon><infon key="pub-id_doi">10.1016/j.immuni.2014.12.010</infon><infon key="pub-id_pmid">25526305</infon><infon key="year">2014</infon><infon key="source">Immunity</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="section_type">REF</infon><infon key="lpage">908</infon><offset>28516</offset><text>NOD1 and NOD2: signaling, host defense, and inflammatory disease</text><annotation id="545"><infon key="identifier">10392</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4440</infon><location offset="28516" length="4"/><text>NOD1</text></annotation><annotation id="546"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="28525" length="4"/><text>NOD2</text></annotation><annotation id="547"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="28560" length="20"/><text>inflammatory disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-34247254780</infon><infon key="name_2">surname:Sellge;given-names:G.</infon><infon key="name_1">surname:Bourhis;given-names:L. L.</infon><infon key="name_0">surname:Fritz;given-names:J. H.</infon><infon key="fpage">445</infon><infon key="issue">4</infon><infon key="pub-id_doi">10.1016/j.immuni.2007.03.009</infon><infon key="pub-id_pmid">17433730</infon><infon key="year">2007</infon><infon key="source">Immunity</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="section_type">REF</infon><infon key="lpage">459</infon><offset>28581</offset><text>Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity</text><annotation id="549"><infon key="identifier">10392</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4440</infon><location offset="28581" length="4"/><text>Nod1</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85066475230</infon><infon key="volume">10</infon><infon key="name_2">surname:Chapman;given-names:T.</infon><infon key="name_1">surname:Shiraishi;given-names:S.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Corridoni;given-names:D.</infon><infon key="fpage">p. 958</infon><infon key="pub-id_doi">10.3389/fimmu.2019.00958</infon><infon key="year">2019</infon><infon key="source">Frontiers in Immunology</infon><infon key="type">ref</infon><offset>28684</offset><text>NOD2 and TLR2 signal via TBK1 and PI31 to direct cross-presentation and CD8 T cell responses</text><annotation id="555"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="28684" length="4"/><text>NOD2</text></annotation><annotation id="556"><infon key="identifier">7097</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20695</infon><location offset="28693" length="4"/><text>TLR2</text></annotation><annotation id="557"><infon key="identifier">29110</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">22742</infon><location offset="28709" length="4"/><text>TBK1</text></annotation><annotation id="558"><infon key="identifier">9491</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">38231</infon><location offset="28718" length="4"/><text>PI31</text></annotation><annotation id="559"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="28756" length="3"/><text>CD8</text></annotation></passage><passage><infon key="name_3">surname:Liu;given-names:Z. J.</infon><infon key="pub-id_other">2-s2.0-84896909529</infon><infon key="name_2">surname:Feng;given-names:B. S.</infon><infon key="name_1">surname:Liu;given-names:C. Q.</infon><infon key="name_0">surname:Xu;given-names:X. R.</infon><infon key="fpage">3255</infon><infon key="issue">12</infon><infon key="pub-id_doi">10.3748/wjg.v20.i12.3255</infon><infon key="pub-id_pmid">24695798</infon><infon key="year">2014</infon><infon key="source">World Journal of Gastroenterology</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="lpage">3264</infon><offset>28777</offset><text>Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease</text><annotation id="561"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="28837" length="26"/><text>inflammatory bowel disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84937578092</infon><infon key="name_1">surname:Levine;given-names:J.</infon><infon key="name_0">surname:Kaistha;given-names:A.</infon><infon key="fpage">328</infon><infon key="issue">11</infon><infon key="pub-id_doi">10.1016/j.cppeds.2014.10.003</infon><infon key="pub-id_pmid">25499459</infon><infon key="year">2014</infon><infon key="source">Current Problems in Pediatric and Adolescent Health Care</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="section_type">REF</infon><infon key="lpage">334</infon><offset>28864</offset><text>Inflammatory bowel disease: the classic gastrointestinal autoimmune disease</text><annotation id="564"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="28864" length="26"/><text>Inflammatory bowel disease</text></annotation><annotation id="565"><infon key="Identifier">MESH:D005767</infon><infon key="type">Disease</infon><location offset="28904" length="35"/><text>gastrointestinal autoimmune disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84958536687</infon><infon key="name_2">surname:Kuroda;given-names:K.</infon><infon key="name_1">surname:Nakamuta;given-names:S.</infon><infon key="name_0">surname:Nagai;given-names:T.</infon><infon key="fpage">550</infon><infon key="issue">3</infon><infon key="pub-id_doi">10.1016/j.neuron.2015.12.019</infon><infon key="pub-id_pmid">26804993</infon><infon key="year">2016</infon><infon key="source">Neuron</infon><infon key="type">ref</infon><infon key="volume">89</infon><infon key="section_type">REF</infon><infon key="lpage">565</infon><offset>28940</offset><text>Phosphoproteomics of the dopamine pathway enables discovery of Rap1 activation as a reward signal in vivo</text><annotation id="568"><infon key="identifier">5906</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2162</infon><location offset="29003" length="4"/><text>Rap1</text></annotation><annotation id="569"><infon key="Identifier">MESH:D004298</infon><infon key="type">Chemical</infon><location offset="28965" length="8"/><text>dopamine</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-0036142395</infon><infon key="name_2">surname:Plasse;given-names:T.</infon><infon key="name_1">surname:van den Blink;given-names:B.</infon><infon key="name_0">surname:Hommes;given-names:D.</infon><infon key="fpage">7</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1053/gast.2002.30770</infon><infon key="pub-id_pmid">11781274</infon><infon key="year">2002</infon><infon key="source">Gastroenterology</infon><infon key="type">ref</infon><infon key="volume">122</infon><infon key="section_type">REF</infon><infon key="lpage">14</infon><offset>29046</offset><text>Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease</text><annotation id="571"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="29140" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="name_3">surname:Peppelenbosch;given-names:M. P.</infon><infon key="name_2">surname:Van Den Brink;given-names:G. R.</infon><infon key="name_1">surname:Ten Hove;given-names:T.</infon><infon key="name_0">surname:Van Den Blink;given-names:B.</infon><infon key="fpage">349</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1111/j.1749-6632.2002.tb04664.x</infon><infon key="pub-id_pmid">12485892</infon><infon key="year">2002</infon><infon key="source">Annals of the New York Academy of Sciences</infon><infon key="type">ref</infon><infon key="volume">973</infon><infon key="section_type">REF</infon><infon key="lpage">358</infon><infon key="name_4">surname:Van Deventer;given-names:S. J.</infon><offset>29156</offset><text>From extracellular to intracellular targets, inhibiting MAP kinases in treatment of Crohn's disease</text><annotation id="573"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="29240" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="name_3">surname:Wakatsuki;given-names:Y.</infon><infon key="pub-id_other">2-s2.0-33748493563</infon><infon key="name_2">surname:Murray;given-names:P. J.</infon><infon key="name_1">surname:Kitani;given-names:A.</infon><infon key="name_0">surname:Watanabe;given-names:T.</infon><infon key="fpage">473</infon><infon key="issue">3</infon><infon key="pub-id_doi">10.1016/j.immuni.2006.06.018</infon><infon key="pub-id_pmid">16949315</infon><infon key="year">2006</infon><infon key="source">Immunity</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="section_type">REF</infon><infon key="lpage">485</infon><infon key="name_5">surname:Strober;given-names:W.</infon><infon key="name_4">surname:Fuss;given-names:I. J.</infon><offset>29256</offset><text>Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis</text><annotation id="577"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="29256" length="43"/><text>Nucleotide binding oligomerization domain 2</text></annotation><annotation id="578"><infon key="identifier">7097</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20695</infon><location offset="29333" length="4"/><text>TLR2</text></annotation><annotation id="579"><infon key="Identifier">MESH:D003092</infon><infon key="type">Disease</infon><location offset="29382" length="7"/><text>colitis</text></annotation></passage><passage><infon key="name_3">surname:Kitani;given-names:A.</infon><infon key="pub-id_other">2-s2.0-84902591511</infon><infon key="name_2">surname:Fuss;given-names:I.</infon><infon key="name_1">surname:Asano;given-names:N.</infon><infon key="name_0">surname:Strober;given-names:W.</infon><infon key="fpage">249</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1111/imr.12193</infon><infon key="pub-id_pmid">24942694</infon><infon key="year">2014</infon><infon key="source">Immunological Reviews</infon><infon key="type">ref</infon><infon key="volume">260</infon><infon key="section_type">REF</infon><infon key="lpage">260</infon><infon key="name_4">surname:Watanabe;given-names:T.</infon><offset>29390</offset><text>Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease</text><annotation id="582"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="29435" length="4"/><text>NOD2</text></annotation><annotation id="583"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="29473" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="name_3">surname:Corazza;given-names:G. R.</infon><infon key="pub-id_other">2-s2.0-84886951561</infon><infon key="name_2">surname:Allan;given-names:P.</infon><infon key="name_1">surname:Biancheri;given-names:P.</infon><infon key="name_0">surname:Geremia;given-names:A.</infon><infon key="fpage">3</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1016/j.autrev.2013.06.004</infon><infon key="pub-id_pmid">23774107</infon><infon key="year">2014</infon><infon key="source">Autoimmunity Reviews</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="section_type">REF</infon><infon key="lpage">10</infon><infon key="name_4">surname:Di Sabatino;given-names:A.</infon><offset>29489</offset><text>Innate and adaptive immunity in inflammatory bowel disease</text><annotation id="585"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="29521" length="26"/><text>inflammatory bowel disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85037604346</infon><infon key="name_2">surname:Stubbington;given-names:M. J. T.</infon><infon key="name_1">surname:West;given-names:N. R.</infon><infon key="name_0">surname:Hegazy;given-names:A. N.</infon><infon key="fpage">1320</infon><infon key="issue">5</infon><infon key="pub-id_doi">10.1053/j.gastro.2017.07.047</infon><infon key="pub-id_pmid">28782508</infon><infon key="year">2017</infon><infon key="source">Gastroenterology</infon><infon key="type">ref</infon><infon key="volume">153</infon><infon key="section_type">REF</infon><infon key="lpage">1337.e16</infon><offset>29548</offset><text>Circulating and tissue-resident CD4+ T cells with reactivity to intestinal microbiota are abundant in healthy individuals and function is altered during inflammation</text><annotation id="588"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="29580" length="3"/><text>CD4</text></annotation><annotation id="589"><infon key="Identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="29701" length="12"/><text>inflammation</text></annotation></passage><passage><infon key="name_3">surname:Munz;given-names:C.</infon><infon key="pub-id_other">2-s2.0-84922394653</infon><infon key="name_2">surname:Oberle;given-names:S. G.</infon><infon key="name_1">surname:Utzschneider;given-names:D. T.</infon><infon key="name_0">surname:Speiser;given-names:D. E.</infon><infon key="fpage">768</infon><infon key="issue">11</infon><infon key="pub-id_doi">10.1038/nri3740</infon><infon key="pub-id_pmid">25257362</infon><infon key="year">2014</infon><infon key="source">Nature Reviews. Immunology</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="section_type">REF</infon><infon key="lpage">774</infon><infon key="name_5">surname:Zehn;given-names:D.</infon><infon key="name_4">surname:Romero;given-names:P.</infon><offset>29714</offset><text>T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion</text><annotation id="592"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="29740" length="17"/><text>chronic infection</text></annotation><annotation id="593"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="29762" length="6"/><text>cancer</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85064452285</infon><infon key="volume">41</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Kurachi;given-names:M.</infon><infon key="fpage">327</infon><infon key="issue">3</infon><infon key="pub-id_doi">10.1007/s00281-019-00744-5</infon><infon key="pub-id_pmid">30989321</infon><infon key="year">2019</infon><infon key="source">Seminars in Immunopathology</infon><infon key="type">ref</infon><infon key="lpage">337</infon><offset>29806</offset><text>CD8+ T cell exhaustion</text><annotation id="595"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="29806" length="3"/><text>CD8</text></annotation></passage><passage><infon key="name_3">surname:Wherry;given-names:E. J.</infon><infon key="pub-id_other">2-s2.0-84864378851</infon><infon key="name_2">surname:Crawford;given-names:A.</infon><infon key="name_1">surname:Blackburn;given-names:S. D.</infon><infon key="name_0">surname:Angelosanto;given-names:J. M.</infon><infon key="fpage">8161</infon><infon key="issue">15</infon><infon key="pub-id_doi">10.1128/JVI.00889-12</infon><infon key="pub-id_pmid">22623779</infon><infon key="year">2012</infon><infon key="source">Journal of Virology</infon><infon key="type">ref</infon><infon key="volume">86</infon><infon key="section_type">REF</infon><infon key="lpage">8170</infon><offset>29829</offset><text>Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection</text><annotation id="598"><infon key="Identifier">MESH:D008569</infon><infon key="type">Disease</infon><location offset="29841" length="16"/><text>loss of memory T</text></annotation><annotation id="599"><infon key="Identifier">MESH:D001102</infon><infon key="type">Disease</infon><location offset="29917" length="15"/><text>viral infection</text></annotation></passage><passage><infon key="name_3">surname:Lyons;given-names:P. A.</infon><infon key="pub-id_other">2-s2.0-84938397867</infon><infon key="name_2">surname:Jayne;given-names:D. R. W.</infon><infon key="name_1">surname:Lee;given-names:J. C.</infon><infon key="name_0">surname:McKinney;given-names:E. F.</infon><infon key="fpage">612</infon><infon key="issue">7562</infon><infon key="pub-id_doi">10.1038/nature14468</infon><infon key="pub-id_pmid">26123020</infon><infon key="year">2015</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">523</infon><infon key="section_type">REF</infon><infon key="lpage">616</infon><infon key="name_4">surname:Smith;given-names:K. G. C.</infon><offset>29933</offset><text>T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection</text><annotation id="602"><infon key="Identifier">MESH:D001327</infon><infon key="type">Disease</infon><location offset="29991" length="12"/><text>autoimmunity</text></annotation><annotation id="603"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="30008" length="9"/><text>infection</text></annotation></passage><passage><infon key="volume">31</infon><infon key="name_2">surname:Eaton;given-names:K. A.</infon><infon key="name_1">surname:Zhao;given-names:L.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Yu;given-names:A. I.</infon><infon key="fpage">p. 107471</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1016/j.celrep.2020.03.035</infon><infon key="pub-id_pmid">32268087</infon><infon key="year">2020</infon><infon key="source">Cell reports</infon><infon key="type">ref</infon><offset>30018</offset><text>Gut microbiota modulate CD8 T cell responses to influence colitis-associated tumorigenesis</text><annotation id="606"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="30042" length="3"/><text>CD8</text></annotation><annotation id="607"><infon key="Identifier">MESH:D003092</infon><infon key="type">Disease</infon><location offset="30076" length="7"/><text>colitis</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85071701589</infon><infon key="name_2">surname:Smids;given-names:C.</infon><infon key="name_1">surname:Wahab;given-names:P. J.</infon><infon key="name_0">surname:Roosenboom;given-names:B.</infon><infon key="fpage">1497</infon><infon key="issue">9</infon><infon key="pub-id_doi">10.1093/ibd/izz049</infon><infon key="pub-id_pmid">30918941</infon><infon key="year">2019</infon><infon key="source">Inflammatory Bowel Diseases</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="section_type">REF</infon><infon key="lpage">1509</infon><offset>30109</offset><text>Intestinal CD103+CD4+ and CD103+CD8+ T-cell subsets in the gut of inflammatory bowel disease patients at diagnosis and during follow-up</text><annotation id="614"><infon key="identifier">3682</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">113560</infon><location offset="30120" length="5"/><text>CD103</text></annotation><annotation id="615"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="30126" length="3"/><text>CD4</text></annotation><annotation id="616"><infon key="identifier">3682</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">113560</infon><location offset="30135" length="5"/><text>CD103</text></annotation><annotation id="617"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="30141" length="3"/><text>CD8</text></annotation><annotation id="618"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="30202" length="8"/><text>patients</text></annotation><annotation id="619"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="30175" length="26"/><text>inflammatory bowel disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85047299163</infon><infon key="volume">9</infon><infon key="name_2">surname:Sudan;given-names:R.</infon><infon key="name_1">surname:Srivastava;given-names:N.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Fernandes;given-names:S.</infon><infon key="fpage">p. 1100</infon><infon key="pub-id_doi">10.3389/fimmu.2018.01100</infon><infon key="year">2018</infon><infon key="source">Frontiers in Immunology</infon><infon key="type">ref</infon><offset>30245</offset><text>SHIP1 deficiency in inflammatory bowel disease is associated with severe Crohn's disease and peripheral T cell reduction</text><annotation id="623"><infon key="identifier">3635</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">4046</infon><location offset="30245" length="5"/><text>SHIP1</text></annotation><annotation id="624"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="30265" length="26"/><text>inflammatory bowel disease</text></annotation><annotation id="625"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="30318" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-85031734883</infon><infon key="name_2">surname:Xing;given-names:J.</infon><infon key="name_1">surname:Zhang;given-names:Y.</infon><infon key="name_0">surname:Ma;given-names:F.</infon><infon key="fpage">135</infon><infon key="issue">1</infon><infon key="pub-id_doi">10.1016/j.yexcr.2017.10.011</infon><infon key="pub-id_pmid">29031634</infon><infon key="year">2017</infon><infon key="source">Experimental Cell Research</infon><infon key="type">ref</infon><infon key="volume">361</infon><infon key="section_type">REF</infon><infon key="lpage">140</infon><offset>30366</offset><text>Fecal bacteria from treatment-naive Crohn's disease patients can skew helper T cell responses</text><annotation id="628"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="30418" length="8"/><text>patients</text></annotation><annotation id="629"><infon key="Identifier">MESH:D003424</infon><infon key="type">Disease</infon><location offset="30402" length="15"/><text>Crohn's disease</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-84920764366</infon><infon key="name_2">surname:Wang;given-names:X.</infon><infon key="name_1">surname:Wan;given-names:Q.</infon><infon key="name_0">surname:Shang;given-names:J.</infon><infon key="fpage">217</infon><infon key="pub-id_doi">10.1016/j.freeradbiomed.2014.12.013</infon><infon key="pub-id_pmid">25528059</infon><infon key="year">2015</infon><infon key="source">Free Radical Biology &amp; Medicine</infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="section_type">REF</infon><infon key="lpage">227</infon><offset>30460</offset><text>Identification of NOD2 as a novel target of RNA-binding protein HuR: evidence from NADPH oxidase-mediated HuR signaling in diabetic nephropathy</text><annotation id="634"><infon key="identifier">64127</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">11156</infon><location offset="30478" length="4"/><text>NOD2</text></annotation><annotation id="635"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="30524" length="3"/><text>HuR</text></annotation><annotation id="636"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="30566" length="3"/><text>HuR</text></annotation><annotation id="637"><infon key="Identifier">MESH:D003928</infon><infon key="type">Disease</infon><location offset="30583" length="20"/><text>diabetic nephropathy</text></annotation></passage><passage><infon key="pub-id_other">2-s2.0-32044436324</infon><infon key="name_2">surname:Ramgolam;given-names:V.</infon><infon key="name_1">surname:Collinge;given-names:M.</infon><infon key="name_0">surname:Wang;given-names:J. G.</infon><infon key="fpage">2105</infon><infon key="issue">4</infon><infon key="pub-id_doi">10.4049/jimmunol.176.4.2105</infon><infon key="pub-id_pmid">16455966</infon><infon key="year">2006</infon><infon key="source">The Journal of Immunology</infon><infon key="type">ref</infon><infon key="volume">176</infon><infon key="section_type">REF</infon><infon key="lpage">2113</infon><offset>30604</offset><text>LFA-1-dependent HuR nuclear export and cytokine mRNA stabilization in T cell activation</text><annotation id="640"><infon key="identifier">3683</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1666</infon><location offset="30604" length="5"/><text>LFA-1</text></annotation><annotation id="641"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="30620" length="3"/><text>HuR</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JIR2020-3067273.001.jpg</infon><infon key="id">fig1</infon><infon key="type">fig_caption</infon><offset>30692</offset><text>Screening DEGs by integrated bioinformatics analysis. The gene expression and connectivity of GSE86434 and GSE94648 (a), GSE86434 and GSE119600 (b), and GSE94648 and GSE119600 (c). After moving batch effects with parametric empirical Bayes frameworks provided by the ComBat function in R package sva, the gene expression and connectivity of GSE86434 and GSE94648 (d), GSE86434 and GSE119600 (e), and GSE94648 and GSE119600 (f). (g) PCA plot for sample clustering of all datasets without batch effect adjustment (A) and with batch effect adjustment (B). (h) Venn diagram of integrative analysis DEGs (Integrated-DE) and DEGs from each individual dataset (Individual-DE).</text></passage><passage><infon key="section_type">FIG</infon><infon key="file">JIR2020-3067273.002.jpg</infon><infon key="id">fig2</infon><infon key="type">fig_caption</infon><offset>31362</offset><text>Top 20 hub genes are identified by network-based analysis. (a) Zero-order interaction network and (b) enrichment network of top 20 hub genes.</text></passage><passage><infon key="section_type">FIG</infon><infon key="file">JIR2020-3067273.003.jpg</infon><infon key="id">fig3</infon><infon key="type">fig_caption</infon><offset>31504</offset><text>ELAVL1 and APP are hub genes measured by network analysis. (a) Enrichment network and (b) zero-order interaction network of upregulated genes identified by network-based analysis. (c) Enrichment network and (d) zero-order interaction network of downregulated genes identified by network-based analysis.</text><annotation id="643"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="31504" length="6"/><text>ELAVL1</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JIR2020-3067273.004.jpg</infon><infon key="id">fig4</infon><infon key="type">fig_caption</infon><offset>31807</offset><text>NOD-like receptor signaling pathway is enriched in the blood of CD by GSE analysis. (a) GSEA-generated heatmaps of core enrichment genes in the NOD-like receptor signaling pathway upregulated in CD patients of three datasets. (b-d) Enrichment maps were used for the visualization of NOD-like receptor signaling pathway enrichment results separately. (e) Integrated enrichment network of the three microarray datasets was generated by NetworkAnalyst. (f) Enrichment map visualizes NOD-like receptor signaling pathway enrichment results from integrated data.</text><annotation id="646"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="32005" length="8"/><text>patients</text></annotation><annotation id="647"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="31895" length="4"/><text>GSEA</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JIR2020-3067273.005.jpg</infon><infon key="id">fig5</infon><infon key="type">fig_caption</infon><offset>32366</offset><text>The transcriptome association between candidate crucial genes and top enriched signaling pathways in the peripheral blood of CD patients. The gene expression correlation between ELAVL1 and selected genes in NLR signaling (a) and correlation between APP and selected genes in MAPK signaling (b) in CD patients analysed using the expression data from the three datasets were represented by scatterplots with regression lines. Pearson correlation coefficients (r) and p values were calculated and shown.</text><annotation id="651"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="32544" length="6"/><text>ELAVL1</text></annotation><annotation id="652"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="32494" length="8"/><text>patients</text></annotation><annotation id="653"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="32666" length="8"/><text>patients</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JIR2020-3067273.006.jpg</infon><infon key="id">fig6</infon><infon key="type">fig_caption</infon><offset>32867</offset><text>T cell proportions are significantly altered in the peripheral blood of CD comparing to health control. The scatterplots show the xCell scores for CD4+ (A) and CD8+ (B) T cells of CD and HC from GSE86434 (a), GSE94648 (b) and GSE119600 (c). *p &lt; 0.05, **p &lt; 0.01, and ***p &lt; 0.001.</text><annotation id="656"><infon key="identifier">920</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">513</infon><location offset="33014" length="3"/><text>CD4</text></annotation><annotation id="657"><infon key="identifier">925</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">133777</infon><location offset="33027" length="3"/><text>CD8</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JIR2020-3067273.007.jpg</infon><infon key="id">fig7</infon><infon key="type">fig_caption</infon><offset>33161</offset><text>ELAVL1 expression correlates with multiple T cell subset activation in the peripheral blood of CD patients. The association between ELAVL1 and the xCell scores of selected T cell subsets of CD patients were analysed using the expression data from GSE86434 (a), GSE94648 (b), and GSE119600 (c). Scatterplots were represented with regression lines. The Spearman correlation coefficients (r) and p values were calculated and shown.</text><annotation id="662"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="33161" length="6"/><text>ELAVL1</text></annotation><annotation id="663"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="33293" length="6"/><text>ELAVL1</text></annotation><annotation id="664"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="33259" length="8"/><text>patients</text></annotation><annotation id="665"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="33354" length="8"/><text>patients</text></annotation></passage><passage><infon key="section_type">FIG</infon><infon key="file">JIR2020-3067273.008.jpg</infon><infon key="id">fig8</infon><infon key="type">fig_caption</infon><offset>33590</offset><text>The schematic diagram illustrating ELAVL1/NLR, APP/MAPK signaling, and T cell migration and/or exhaustion in CD pathogenesis.</text><annotation id="667"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="33625" length="6"/><text>ELAVL1</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tab1.xml</infon><infon key="id">tab1</infon><infon key="type">table</infon><offset>33716</offset><text>Disease Datasets Platform Cases Controls References Exploration       CD GSE86434 GPL10558 23 24   CD GSE94648 GPL19109 50 22   CD GSE119600 GPL10558 95 47  Validation       IBD PRJEB28822 Ion AmpliSeq Transcriptome Human Gene Expression Panel 102 51  Pediatric Pediatric 95 46  Adult Adult </text><annotation id="670"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="33932" length="5"/><text>Human</text></annotation><annotation id="671"><infon key="Identifier">MESH:D015212</infon><infon key="type">Disease</infon><location offset="33890" length="3"/><text>IBD</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tab1.xml</infon><infon key="id">tab1</infon><infon key="type">table_caption</infon><offset>34016</offset><text>Gene expression datasets used in this study.</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tab2.xml</infon><infon key="id">tab2</infon><infon key="type">table</infon><offset>34061</offset><text>Gene DC BC Expression APP 1056 4730653 -33.853 EGFR 580 1711465 -15.619 ELAVL1 574 1999916 34.987 CAND1 381 578227.8 24.477 ITGA4 370 457397.4 -15.926 SIRT7 357 744489.5 -45.873 FBXO6 352 760217.7 -53.7 CCDC8 322 504043 -15.191 GRB2 303 630311.8 -26.82 TP53 281 621198.7 20.389 MOV10 260 573433.5 -20.408 NXF1 241 496040.6 -23.619 MYC 239 458057 21.06 HSP90AA1 232 486480.7 28.182 HUWE1 232 242665.7 26.081 LRRK2 223 216252.1 -31.578 COPS5 220 313401.8 48.805 ARRB2 219 230981.9 -42.185 PAN2 217 168810.6 30.93 CUL5 208 174910.9 22.703 </text><annotation id="680"><infon key="identifier">1994</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">20367</infon><location offset="34133" length="6"/><text>ELAVL1</text></annotation><annotation id="681"><infon key="identifier">55832</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">10202</infon><location offset="34159" length="5"/><text>CAND1</text></annotation><annotation id="682"><infon key="identifier">83987</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">49977</infon><location offset="34264" length="5"/><text>CCDC8</text></annotation><annotation id="683"><infon key="identifier">2885</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">1576</infon><location offset="34289" length="4"/><text>GRB2</text></annotation><annotation id="684"><infon key="identifier">120892</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">18982</infon><location offset="34468" length="5"/><text>LRRK2</text></annotation><annotation id="685"><infon key="identifier">10482</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">38176</infon><location offset="34366" length="4"/><text>NXF1</text></annotation><annotation id="686"><infon key="identifier">1956</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">74545</infon><location offset="34108" length="4"/><text>EGFR</text></annotation><annotation id="687"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="34548" length="4"/><text>PAN2</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tab2.xml</infon><infon key="id">tab2</infon><infon key="type">table_caption</infon><offset>34598</offset><text>Top 20 hub genes with DC and BC.</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tab3.xml</infon><infon key="id">tab3</infon><infon key="type">table</infon><offset>34631</offset><text>Term Count Gene p value Endometrial cancer 4 20% 3.65e-6 Colorectal cancer 4 20% 1.77e-5 Prostate cancer 4 20% 2.85e-5 PI3K-Akt signaling pathway 6 30% 3.1e-5 Bladder cancer 3 15% 6.01e-5 Breast cancer 4 20% 1.45e-4 MAPK signaling pathway 5 25% 1.71e-4 </text><annotation id="694"><infon key="identifier">207</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">3785</infon><location offset="34755" length="3"/><text>Akt</text></annotation><annotation id="695"><infon key="Identifier">MESH:D016889</infon><infon key="type">Disease</infon><location offset="34655" length="18"/><text>Endometrial cancer</text></annotation><annotation id="696"><infon key="Identifier">MESH:D015179</infon><infon key="type">Disease</infon><location offset="34688" length="17"/><text>Colorectal cancer</text></annotation><annotation id="697"><infon key="Identifier">MESH:D011471</infon><infon key="type">Disease</infon><location offset="34720" length="15"/><text>Prostate cancer</text></annotation><annotation id="698"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="34798" length="6"/><text>cancer</text></annotation><annotation id="699"><infon key="Identifier">MESH:D001943</infon><infon key="type">Disease</infon><location offset="34819" length="13"/><text>Breast cancer</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tab3.xml</infon><infon key="id">tab3</infon><infon key="type">table_caption</infon><offset>34885</offset><text>KEGG analysis of the 20 hub genes identified by network-based analysis.</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tab4.xml</infon><infon key="id">tab4</infon><infon key="type">table</infon><offset>34957</offset><text>GSE86434 GSE94648 GSE119600 Integrated Name Enrichment score Name Enrichment score Name Enrichment score Name Enrichment score NOD-like receptor signaling pathway 0.64066 Huntington's disease 0.453565 Pathways in cancer 0.404973 MAPK signaling pathway 0.446547 Kaposi's sarcoma-associated herpesvirus infection 0.473815 Alzheimer's disease 0.486581 Endocytosis 0.426882 Kaposi's sarcoma-associated herpesvirus infection 0.499763 Tuberculosis 0.48882 Alcoholism 0.509264 MAPK signaling pathway 0.462268 Rap1 signaling pathway 0.517768 Chemokine signaling pathway 0.474491 NOD-like receptor signaling pathway 0.492519 Proteoglycans in cancer 0.46461 NOD-like receptor signaling pathway 0.633331 Influenza A 0.504921 Nonalcoholic fatty liver disease (NAFLD) 0.487171 Kaposi's sarcoma-associated herpesvirus infection 0.454893 Tuberculosis 0.549604 Alcoholism 0.597721 Parkinson's disease 0.573813 Regulation of actin cytoskeleton 0.48289 Influenza A 0.505989 Necroptosis 0.526145 Lysosome 0.453183 Rap1 signaling pathway 0.524153 Hepatitis B 0.536561 Phagosome 0.515787 Oxidative phosphorylation 0.614682 Tuberculosis 0.47918 Alcoholism 0.488690 Hepatitis C 0.558024 Systemic lupus erythematosus 0.625444 Focal adhesion 0.501669 Necroptosis 0.525488 Osteoclast differentiation 0.615345 Huntington's disease 0.517828 NOD-like receptor signaling pathway 0.500948 Phagosome 0.513988 </text><annotation id="721"><infon key="identifier">5906</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2162</infon><location offset="35459" length="4"/><text>Rap1</text></annotation><annotation id="722"><infon key="identifier">5906</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">2162</infon><location offset="35952" length="4"/><text>Rap1</text></annotation><annotation id="723"><infon key="identifier">37296</infon><infon key="type">Species</infon><location offset="35218" length="39"/><text>Kaposi's sarcoma-associated herpesvirus</text></annotation><annotation id="724"><infon key="identifier">37296</infon><infon key="type">Species</infon><location offset="35327" length="39"/><text>Kaposi's sarcoma-associated herpesvirus</text></annotation><annotation id="725"><infon key="identifier">37296</infon><infon key="type">Species</infon><location offset="35721" length="39"/><text>Kaposi's sarcoma-associated herpesvirus</text></annotation><annotation id="726"><infon key="Identifier">MESH:D006816</infon><infon key="type">Disease</infon><location offset="35128" length="20"/><text>Huntington's disease</text></annotation><annotation id="727"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="35170" length="6"/><text>cancer</text></annotation><annotation id="728"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="35258" length="9"/><text>infection</text></annotation><annotation id="729"><infon key="Identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="35277" length="19"/><text>Alzheimer's disease</text></annotation><annotation id="730"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="35367" length="9"/><text>infection</text></annotation><annotation id="731"><infon key="Identifier">MESH:D014376</infon><infon key="type">Disease</infon><location offset="35386" length="12"/><text>Tuberculosis</text></annotation><annotation id="732"><infon key="Identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="35590" length="6"/><text>cancer</text></annotation><annotation id="733"><infon key="Identifier">MESH:D065626</infon><infon key="type">Disease</infon><location offset="35671" length="32"/><text>Nonalcoholic fatty liver disease</text></annotation><annotation id="734"><infon key="Identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="35761" length="9"/><text>infection</text></annotation><annotation id="735"><infon key="Identifier">MESH:D014376</infon><infon key="type">Disease</infon><location offset="35780" length="12"/><text>Tuberculosis</text></annotation><annotation id="736"><infon key="Identifier">MESH:D010300</infon><infon key="type">Disease</infon><location offset="35822" length="19"/><text>Parkinson's disease</text></annotation><annotation id="737"><infon key="Identifier">MESH:D006509</infon><infon key="type">Disease</infon><location offset="35984" length="11"/><text>Hepatitis B</text></annotation><annotation id="738"><infon key="Identifier">MESH:D014376</infon><infon key="type">Disease</infon><location offset="36059" length="12"/><text>Tuberculosis</text></annotation><annotation id="739"><infon key="Identifier">MESH:D006526</infon><infon key="type">Disease</infon><location offset="36080" length="31"/><text>Alcoholism 0.488690 Hepatitis C</text></annotation><annotation id="740"><infon key="Identifier">MESH:D008180</infon><infon key="type">Disease</infon><location offset="36121" length="28"/><text>Systemic lupus erythematosus</text></annotation><annotation id="741"><infon key="Identifier">MESH:D006816</infon><infon key="type">Disease</infon><location offset="36240" length="20"/><text>Huntington's disease</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tab4.xml</infon><infon key="id">tab4</infon><infon key="type">table_caption</infon><offset>36335</offset><text>GSEA analysis of the three microarray datasets.</text><annotation id="743"><infon key="Identifier">-</infon><infon key="type">Chemical</infon><location offset="36335" length="4"/><text>GSEA</text></annotation></passage></document></collection>